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Abstract 
Responsive polymer-based gold nanoparticles are capable of altering their unique 
optical properties, chemical and/or physical properties upon exposure to external 
stimuli, which allows these materials to use in a diverse range of biomedical 
applications.  
Herein, the use of temperature responsive polymers and glycopolymers functionalised 
gold nanoparticles is given as sensors and biosensors, for controlled and triggered 
target detection. Chapter 2 investigates the transition characterisation and thermal 
aggregation co-operative behaviour of thermo-responsive polymer conjugated gold 
nanoparticles for a detailed understanding of fundamental features to apply in a 
biosensing system. Chapter 3 develops an optical, gold nanoparticle-based biosensor 
for the detection of specific biological target. Both temperature responsive and 
molecular recognizable polymers co-coated gold nanoparticles that change colour by 
protein-carbohydrate interaction mediated interparticular aggregation are controllable 
at desired condition. Optimisation of the particle coating is very essential to enhance 
the sensitivity and specificity of the biosensing system. Finally, this strategy is then 
extended and improved in Chapter4, with a larger glycans for probing control over the 
expression of particle surface glycans triggering carbohydrate-carbohydrate 
interactions with high specificity and selectivity, effectively. In summary, 
functionalised polymers and gold nanoparticles have been synthesized and developed 
as a biosensor. These gold nanoparticle conjugates may promise a powerful solution 
for rapid and reliable identification of disease and point-of-care treatment in modern 
healthcare issue. 
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Chapter 1 
1. Introduction 
 
1.1 Nanotechnology: need and importance of 
gold nanoparticles for bio applications 
Modern healthcare needs rapid and reliable identification of disease for point-of-care 
treatment. To meet this strong demand, nanotechnologies dealing with in the range of 
5 to 200 nanometer size materials have been rapidly expanding and developing in the 
last two decades. The current global market of nanotechnology used in drug 
development and drug delivery has been dramatically increasing. The total market size 
for all of these fields is expected to be over US$136 billion in 2021 with an annual 
growth of 15 %.1 
 
Figure 1.1 Global market trends for nanotechnology in drug delivery 2011-21, figure 
adapted from reference 1. 
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Metal nanoparticles are one of the most widely used forms among various materials 
in the clinical field (for therapeutics or diagnostics) due to their unique characteristics 
such as unique optical properties originates from the photophysical response, high 
surface-to-volume ratio, ease of synthesis, and straightforward surface chemistry and 
functionalization. Moreover, gold nanoparticles (AuNPs) based materials have been 
developed and showing therapeutic performance as advanced medical applications. 
For example, AuNPs can efficiently convert light or radiofrequencies into heat for 
hyperthermia treatment of targeted cancer cells2,3 and form the basis of lateral flow 
assays such as those used in home pregnancy tests.4 
 
1.1.1 Optical and electronic properties of gold 
nanoparticles 
The interaction of light with surface free electrons of the gold nanoparticle (conduction 
band electrons) bestows unique electrical, conductive and optical properties of gold 
nanoparticle. Surface electron are forming a ‘cloud’ and electron clouds are excited 
and vibrated as a wave with a certain energy value by light at a specific wavelength 
(frequency). This electron oscillation causes a charge separation resulting in a 
collective dipole oscillation along the direction of the electric field of the light, called 
surface plasmon resonance (SPR). A strong absorption of the incident light induced 
by the SPR can be measured using an ultraviolet-visible (UV-Vis) absorption 
spectrometer. 
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Figure 1.2 Basics of localized surface plasmon resonance (LSPR) of gold 
nanoparticles due to collective oscillation of surface electrons with incident light at a 
specific wavelength. 
 
The SPR phenomenon of small (~30 nm) gold nanoparticle colloids causes an 
absorption of light at ~400-500 nm wavelength (blue-green portion of electromagnetic 
spectrum) while ~700 nm wavelength (red light) is reflected, yielding particle 
solutions with a red colour. The absorption wavelength of SPR shifts to longer 
wavelengths as increasing particle size, and consequently particles absorb red light 
and reflect blue light, giving blue-purple colour of nanoparticles. These properties 
have been used to create colourimetric biosensors based upon the target causing 
agglutination (aggregation) and hence generating a signal output.5 Plasmon resonance 
associated-absorption wavelengths shift from blue to red while reflection light shifts 
from red to blue when particles aggregate together in the presence of analytes from 
individual small particle. Therefore, particle solutions exhibits visible colour change 
from red to blue on aggregation. Gold nanoparticles optical and electronic properties 
according to SPR phenomenon can be tuned by change particle characteristics for 
further applications. The electron charge density on the particle surface have an effect 
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on the SPR band intensity and wavelength and it depends on several factors such as 
the particle size, shape, structure, composition, surface chemistry, aggregation state 
and the dielectric constant surrounding medium as described by Mie theory.6 
 
 
Figure 1.3 Various colours of gold nanoparticles solutions depending on particle size, 
figure adapted from reference 7. 
 
 
1.1.2 Applications for imaging, biosensing and, 
as functional scaffolds 
One of the most familiar bio applications is the home pregnancy test by using gold 
nanoparticles to generate signal in a lateral flow assay. Gold nanoparticles (< 50 nm) 
are conjugated with antibodies complementary to a target human chorionic 
gonadotropin (hCG) hormone in urine produced during pregnancy. Also, target analyte 
antibodies are immobilized in a line on a nitrocellulose or cellulose acetate membrane. 
nm
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When the test stick is submerged in urine flow, if the hCG hormone is present it will 
bind to the gold nanoparticle first, and then be captured by antibodies on the membrane. 
This flow assay produces an observable coloured line due to particle aggregates using 
sandwich method. 
 
Figure 1.4 Gold nanoparticles for use in cytodiagnostics products (pregnancy test), 
figure adapted from reference 8. 
 
Gold nanoparticles possess several physicochemical advantages allowing potential 
therapeutic and diagnostic applications. First, safety (intrinsic nontoxicity, low 
cytotoxicity) and biocompatibility both in vitro and in vivo with minimal inflammatory 
activation and few side effects.9-13 Second, easy fabrication of particle with structure 
variation, spherical gold nanoparticles (nanospheres) can be easily synthesized in 
uniform size via classic Turkevich method using HAuCl4 salt reduction by sodium 
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citrate in aqueous medium under reflux condition.14 Also, different shapes such as 
nanorods, nanoshells, nanocages and nanostars can be obtained by various methods as 
shown in Figure 1.5.15-21 
 
 
Figure 1.5 TEM images of various types of gold nanoparticles: A) nanospheres, B) 
nanorods, C) silica/gold nanoshells, D) nanobowls with a gold seed on the bottom, E) 
nanocubes and nanocages, F) nanostars, G) bipyramids and H) octahedrals, figure 
adapted from reference 22. 
 
Third, various biologically useful materials including antibodies, DNA and RNA are 
capable of being conjugated and functionalised with gold nanoparticles by 
electrostatic interactions between particles and biological molecules.23 This leads to 
improvement of stability, tumor-targeting, evade immune detection and crossing of 
biophysical barriers.24,25 Fourth, surface plasmon resonance phenomenon and Raman 
scattering activity of gold nanoparticles have been exploited in non-radiation based 
imaging applications, tomography of tumors, drug delivery vehicles, tumor-specific 
photothermal therapy agents and molecular reporters.15,26 Lastly, gold’s high 
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absorption and enhancement of ionizing radiation can be used for radiation-based 
therapeutic to enhance the tumor-killing efficiency and diagnostic applications as well 
as X-ray contrast agent for imaging.27-31 
 
Figure 1.6 Versatility of gold nanoparticles, figure adapted from reference 32. 
 
Therefore, various ligands and gold particle surface modifications have been 
employed to achieve better stability of gold nanoparticles, encapsulation of a 
therapeutic agent, imaging resolution and sensitivity, molecular recognition 
capabilities and stimulus responsive controlled release drug delivery.33 Especially, 
responsive polymer based gold nanoparticle is a potential solution to increase the 
therapeutic performance and efficiency. 
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1.2 Responsive polymer 
Polymers are described as covalently bonded macromolecular structure composed of 
many repeating subunits (monomers). Since the modern concept of polymer was 
defined by Staudinger,34,35 these synthetic and nature material plays a crucial role in 
everyday our life due to their broad range of properties. Also, the development of a 
new class of polymers in the biomedical fields is desperate due to the higher living 
standard and the great concern for health care issue. As a result, a number of 
researchers have been developing new type of polymers called stimuli-responsive 
polymers (or smart/intelligent polymer), which are able to respond to environment by 
changing their chemical and/or physical properties.36-38  
Stimulus-responsive polymers can change their conformation and exhibit their 
properties when a variety of external stimuli, such as temperature, pH, solvent, light, 
ions, mechanical force, the various small molecules and biomolecules and 
electric/magnetic fields are applied.39-49 These unique properties and abilities can 
allow polymers to adapt to various biomedical fields including biosensor,50 drug 
delivery51 and many other applications52-54 in a number of forms such as simple 
polymer solutions, hydrogels, micelles, films and layers.55-59 
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Figure 1.7 ‘Galaxy’ of nanostructured stimuli-responsive polymer materials. The 
phase behaviour of responsive polymer in versatile forms, figure adapted from 
reference 59. 
 
1.2.1 Temperature responsive polymer 
Temperature responsivity is the most extensively studied and widely investigated for 
biomedical applications. Temperature-responsive polymers in solution have a certain 
temperature exhibiting a phase transition which causes an abrupt change in their 
solvation. Some polymers are soluble and miscible below the certain temperature 
whereas polymers are insoluble and immiscible upon heating above the critical 
temperature which is called a lower critical solution temperature (LCST). On the 
contrary, polymers become soluble upon heating, have an upper critical solution 
temperature (UCST). 
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In the aqueous systems, polymer chains form an extended random coil in one 
homogeneous mixed phase by hydrogen bonding with surrounding water molecules. 
When heated above the LCST, polymer chains collapse to a compact (desolvated) 
globular conformation due to intra- and intermolecular hydrogen bonding of polymer 
molecules are favoured compared to a solubilisation by water molecule.60-66 Also, 
intra- and intermolecular hydrophobic interactions of partially collapsed polymer 
chains enhance the phase transition (separation).67,68 
 
 
Figure 1.8 Schematic illustration of the ‘coil-to-globule’ polymer conformation 
change upon heating above the LCST. 
 
The critical temperature should only be used as the terms of LCST/UCST at the 
minimum (LCST) or the maximum (UCST) point on the diagram respectively, when 
the phase diagram of a polymer/solvent mixture vs. temperature showing both one-
phase and two-phase region (Figure 1.9). It is more suitable to use ‘cloud point (CP)’ 
term associated with macroscopic effect as transition temperature for any other 
transition from soluble to insoluble or vice versa at a given concentration (solution 
composition) without this phase diagram.69 However, transition temperature of some 
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polymers like poly(N-isopropylacrylamide) (pNIPAM) is nearly identical to the LCST 
at any given concentration.70 
 
Figure 1.9 Temperature vs. polymer volume fraction (). Schematic illustration of 
phase diagrams for polymer solution A) lower critical solution temperature (LCST) 
behaviour and B) upper critical solution temperature (UCST) behaviour. 
 
There are a variety of polymers exhibiting LCSTs properties, Table 1.1 and Figure 
1.10 show either LCST or UCST of selected polymers in aqueous solution and their 
chemical structure. These polymers have the transition temperature in the region from 
20 to 40 oC.71 
First, poly(N-isopropylacrylamide) (pNIPAM) is one of the most well-known polymer 
having a LCST from 30 oC to 35 oC.72-75 The LCST of pNIPAM allows this 
biocompatible material to use in controlled release applications and this transition 
temperature is almost independent of the concentration, molecular weight based on 
gel permeation chromatography (GPC) analysis (over ~ 10 kg mol-1) and end group of 
pNIPAM.70 Poly(N,N-diethylacrylamide) (pDEAM) has a nearly identical transition 
temperature at 32 – 34 oC which depends on the tacticity of the polymer.76 Poly(N-
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vinyl caprolactam) (pVC) also possesses temperature responsive properties including 
solubility in water and organic solvents, biocompatibility and high absorption ability 
for biomedical applications.77 The transition temperature of poly(methyl vinyl ether) 
(pMVE) is exactly 37 oC. pMVE is synthesized by cationic polymerization using inert 
condition and this polymer showing different thermal demixing behaviour to 
pNIPAM.78 Poly(N-ethyl oxazoline)s (pEtOx) have a high transition temperature 
around 62 oC. In order to decrease a transition temperature and obtain potential in drug 
delivery application, modification of pNIPAM backbone by grafting polymerization 
of EtOx have developed recently.79 If hydrophobic and hydrophilic residues are well 
balanced then elastin like oligo-and polypeptides also show LCST behaviour. For 
example, poly(pentapeptide) of elastin consists of repeating peptide unit GVGVP (G: 
Glycine, V: Valine, and P: Proline) and poly(GVGVP) exhibits a phase transition 
temperature at 30 oC. Above this phase transition temperature, polymer is stable as a 
secondary supramolecular structure by hydrophobic folding and assembling 
transition.80 A responsive doxorubicin-polypeptide conjugate for cancer therapy have 
been designed by Chilkoti et al.81,82 Lastly, a combination of poly acrylamide (pAAm) 
and poly(acrylic acid) (pAAc) with an interpenetrating network has a transition 
temperature at 25 oC. The poly(acrylamide-co-acrylic acid) particularly shows UCST 
behaviour due to co-operative effects by hydrogen bonding between pAAm and 
pAAc.83,84 
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Table 1.1 Selected polymers temperature region exhibiting LCST or UCST 
behaviour.71 
Polymer Phase transition temperature 
in aqueous solution 
LCST behaviour:  
Poly(N-isopropylacrylamide) 30 – 35 oC 
Poly(N,N-diethylacrylamide) 32 – 34 oC 
Poly(N-vinylcaprolactam) 30 – 50 oC 
Poly(methyl vinyl ether) 37 oC 
Block copolymer of poly(ethylene oxide) and 
poly(propylene oxide)s 
20 – 85 oC 
Poly(pentapeptide) of elastin 28 – 30 oC 
UCST behaviour:  
Poly(acrylamide-co-acrylic acid) 25 oC 
 
 
 
Figure 1.10 Chemical structure of temperature responsive polymer exhibiting LCST 
or UCST. 
 
pNIPAM pDEAM pVCap
pMVE pEtOx p(AAm-co-AAc)
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1.2.2 Influence factors on the phase transition 
temperature 
Tuning the phase transition temperature of responsive polymers for cancer treatment 
and targeted drug delivery may have more benefits than conventional hyperthermic 
treatments or thermotherapy method. Because of the exact (desired) temperature 
where materials transition occurs for specific targeted tumour cell or tissue can be 
controlled without external heat energy sources. The LCST behaviour of temperature 
responsive polymer strongly depends on the hydrophilic/hydrophobic balance within 
the polymer molecules and the solvent interaction with the polymer. The phase 
separation boundary of a system can be increased or decreased such that an insoluble 
polymer globule can be a soluble coil (Figure 1.11A) or vice versa (Figure 1.11B) at a 
fixed temperature through hydrophilic/hydrophobic balance changes in the 
surrounding environment. 
 
Figure 1.11 Schematic illustration of phase diagrams for polymer solution exhibiting 
an isothermal LCST transition at a fixed temperature. 
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It should be noted that the phase transition temperature of an aqueous polymer solution 
can be tailored by several factors affecting on hydrophilic/hydrophobic balance 
changes in polymer/solvent system, such as polymer composition (structure), 
molecular weight, end-group, concentration, solvent quality (presence of additives) 
and salt concentration.85-87 
 
Figure 1.12 Polymer structure/solvent system for tuning the phase transition system. 
 
The coil to globule phase transition of polymer can be affected by adjusting the 
polymer composition of hydrophilic or hydrophobic monomer. Copolymerization with 
more hydrophilic (less hydrophobic) monomer increases the LCST, while less 
hydrophilic (more hydrophobic) monomer decreases the LCST of polymer.88-90 Also, 
the molecular weight and incorporation of polymer end groups have influence on the 
LCST. For instance, low molecular weight of pNIPAM (below ~ 10 kg mol-1 based on 
GPC analysis) displays molecular weight dependent LCSTs, but only within a narrow 
Polymer 
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End-group
Solvent
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Mw range.
91-93 The LCST is decreased as increasing the molecular weight due to 
pNIPAM with higher molecular weight shows much larger conformational change 
upon heating.94 But this trend is reversed when the LCST is influenced by 
incorporation hydrophobic end groups. The LCST shifts lower when the proportion of 
hydrophobic end groups of pNIPAM oligomers become larger due to the relative 
influence for total hydrophobicity of polymer as shown in Figure 1.13.95 However, the 
LCST of high molecular weight pNIPAM (over ~ 10 kg mol-1 based on GPC analysis) 
is almost independent of the molecular weight and end groups.96 
 
Figure 1.13 Schematic illustration of incorporation end-group effect on the LCST of 
polymer with different molecular weight. 
 
Solvent system altered by additives (salt, surfactants, and co-solvent) can influence 
the phase transition through changes of polymer-solvent interactions. Salt effect on the 
LCST of temperature responsive polymer pNIPAM has been reported by some 
studies.97,98 The addition of salt plays a pivotal role in the decrease of LCST called 
‘salting-out effect’ due to increases of pNIPAM hydrophobicity through polymer 
structure changes and interaction with surrounded water molecules. Cremer and co-
workers described three basic interactions among salt anions, polymer and water as 
shown in Figure 1.14.99 A surface tension related to the LCST between hydrophobic 
Heat
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parts of polymer (hydrocarbon backbone and isopropyl group) and neighboring 
hydration water can be modulated by salts. The transition temperature can be shifted 
lower by direct binding of the anion from salt to the amide group of pNIPAM. Salt 
anions could polarize water molecule and destabilize hydrogen bonding of the amide 
group in pNIPAM. However, some other types of salt ions and salt concentration can 
increase the LCST of polymer described as ‘salting-in effect’ due to Hofmeister effect. 
 
 
Figure 1.14 Three basic interactions among anions, pNIPAM, and hydration waters 
for effects of Hofmesiter anions on the LCST of pNIPAM, figure adapted from 
reference 99. 
 
Amphiphilic surfactants absorbed by polymer molecules causes altered 
hydrophilic/hydrophobic balance within polymer. This leads to large shifts of 
transition temperature or even disappearance of transition temperature. Polymers can 
undergo other types of aggregation forms such as micellisation in contrast with coil-
to-globule transition upon addition of surfactants.77 Both pVC and pNIPAM show 
increased transition temperature with increasing concentration of ionic surfactant like 
sodium dodecyl sulfate (SDS).77,100 
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1.3 Reversible deactivation radical 
polymerization (RDRP) 
In order to prepare the polymers for a number of biomedical applications, control over 
the polymer architecture including molecular weight, molecular weight distribution 
also referred to as a polydispersity index (PDI), functionality, and composition is 
highly desirable due to many useful properties of polymers result from their structure 
and molecular weight. 
‘Living’ polymerization was developed by Michael Szwarc through the anionic 
polymerization of styrene with an sodium/naphthalene system in 1950s for using more 
precisely controlled polymers.101,102 This technique is a form of chain growth 
polymerization defined as polymerization reactions where chain termination or chain 
transfer reaction is removed(absent)/minimized. Living polymerization offers 
precision and control in macromolecular synthesis through linear molecular weight 
process (growth) with time until all monomer is consumed or intentionally terminated. 
Since 1970s, several new methods called reversible deactivation radical 
polymerization (RDRP) have been discovered which allowed living polymerization to 
use free radical chemistry, also referred to as living or controlled radical 
polymerization (C(L)RP). These techniques can be used with a wide range of vinyl 
monomers for various applications and the robust polymerization condition of RDRP 
provides benefits for new materials design (well-defined polymers) compared to 
conventional radical polymerization (RP).103,104 
RDRP techniques include atom transfer radical polymerization (ATRP),105 nitroxide-
mediated polymerization (NMP),106 and reversible addition-fragmentation chain 
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transfer (RAFT)107 polymerization. All of these RDRP techniques work by 
establishing a dynamic equilibrium between a small fraction of active polymerizing 
chains (propagating radical) and a major fraction of dormant species. This leads to 
promote fast initiation with respect to propagation, and therefore reduce chain 
termination as a state of ‘living’.108,109 
ATRP is a catalytic process using a metal complex, typically copper (the two oxidation 
states are CuI and CuII) and N-containing ligands as catalysts which determine the rate 
of monomer addition to the propagating polymer chain end. One primary limitation of 
the ATRP is a requirement of long-time purification to remove high amounts of the 
catalyst.110,111 In NMP, the polymerization is thermally initiated in the absence of an 
external radical source or a metal catalyst. An alkoxyamine is used for the initiating 
materials to generate the reversible end-capping of growing polymer chains with a 
nitroxide species and they are able to protect the growing chain end from termination 
steps.112,113 
 
Figure 1.15 General mechanism for RDRP, copper-mediated ATRP and NMP 
polymerization processes. 
RDRP
ATRP
NMP
Polymerization Dormant
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1.3.1 RAFT polymerization 
RAFT polymerization is a one of reversible deactivation radical polymerization 
processes discovered at CSIRO of Australia in 1998.107 Currently, this polymerization 
is one of the most versatile and effective way of living free-radical polymerization 
with many benefits. 
Major advantages of the RAFT polymerization process are demonstrated by its ability 
to control polymerization of most monomers including (meth)acrylates, 
(meth)acrylamides, acrylonitrile, styrenes, dienes, and vinyl monomers. In addition, 
its compatibility with a very wide range of reaction conditions (e.g. bulk, organic or 
aqueous solution, emulsion, suspension) and functional monomers such as acid, acid 
salt, hydroxy and tertiary amino groups.114 It can also tolerate dithio-compounds and 
the initiator. This process offers a predetermined molecular weight and very narrow 
polydispersity polymers including functional end or side chain in a one step process 
without any need for protection and deprotection.115 Furthermore, blocks, comb, brush, 
stars and polymers of more complex architectures can be tailored by RAFT 
polymerization.116 The RAFT process involves RAFT agent or chain transfer agent 
(CTA) which mediate the polymerization via a reversible chain-transfer process, 
typically used RAFT agents have a thiocarbonylthio group (S=C-S) with substituents 
R and Z such as dithioesters,107 trithiocarbonates,117,118 ditihiocarbamates,119 and 
xanthates 120 as shown in Figure 1.16. 
 
Figure 1.16 Chemical structure of the four main classes of RAFT agents. 
Dithioester Trithiocarbonate Dithiocarbamate Xanthate
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A sequence of the RAFT polymerization mechanism consists of several key steps: 
initiation, propagation, initial equilibrium, re-initiation, main equilibrium, termination 
as shown in Figure 1.17. 
First, the initiation step is started by a free-radical source through the thermal 
decomposition of radical initiator such as 4,4′-azobis(4-cyanovaleric acid) (ACVA). 
The decomposed radical fragment (I•) react with a single monomer (M) to form a 
propagating polymeric radical (Pn•) and propagating radical chains added to monomer 
to yield a longer propagating radicals. Following initiation, an initial equilibrium is 
achieved, the CTA (S=C(Z)S-R) reacts with a propagating polymeric radical with n 
monomer units (Pn•) to give an intermediate radical species. This radical species is 
broken down into a polymeric adduct of CTA (S=C(Z)S-Pn) and a new free radical 
(R•). This is a reversible step in which the intermediated CTA adduct radical can lose 
either the polymeric species (Pn•) or the R group (R•). The liberated radical (R•) reacts 
with a monomer (M) to form a new propagating radical (Pm•) (for initiating 
polymerization) in the re-initiation step. Then, the main equilibrium is established by 
the addition of the polymer radical (Pm•) to the CTA polymer adduct while releasing 
the other radical (Pn•) due to rapid exchange between the growing radical species (Pn•, 
Pm•) and the CTA polymer adduct (S=C(Z)S-Pn). In an ideal RAFT process, the 
radicals can add to (react with) all chains equally, causing equal chain growth and 
hence control over the narrow molecular weight distribution. Finally, the active 
propagating chains cannot react further via bi-radical termination process and the CTA 
adduct radical is suppressed to do not undergo termination reactions. 
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Figure 1.17 The mechanism of RAFT polymerization process.121 
 
It is very important (should be highlighted) to use appropriate RAFT agents for the 
success of polymer synthesis with a high degree of functionality and narrow molecular 
weight distribution (less than 1.2). The effectiveness of RAFT agents depends on the 
R and Z groups that impact the polymerization reaction kinetics, reactivity and 
solubility. For an effective RAFT agent, the ‘R’ group must be able to reinitiate 
polymerization and be a good homolytic leaving group. The ‘Z’ group should control 
the reactivity of the C=S double bond which influences the rate of radical addition and 
fragmentation. 
Initiation
Chain transfer
Re-initiation
Chain equilibrium
Termination
M: Monomer, R: a radical that can initiate polymerization 
Pn and Pm: polymer chains
Overall process
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Moreover, the RAFT agent leads to the suitable polymerization process for 
functionalizing at both ends of the polymer chain. Polymers produced by RAFT 
polymerization possess a ‘R’ fragment where the site of polymer growth is at the alpha 
() terminus of the polymer. The omega () terminus of the polymer contains a radical 
stabilizing functional group ‘Z’ fragment of the RAFT agent affected by covalent bond 
with thiocarbonylthio moiety (Figure 1. 18).122 
 
Figure 1. 18 RAFT agent and resulting RAFT polymer, showing the -end (R) and 
-end (Z). 
 
Incorporated -functional group onto polymer chain by designed of the R group of 
RAFT agent can produce carboxylic acid,123 peptide124 and lipid -end functionalised 
polymers,125 while the -end group can be controlled through modification of the Z 
group or by post-modification of the thiocarbonyl group after polymerization.126 
For the major study in this thesis, a functionalised polymer containing a thiol end 
group at the -terminus is employed to react with a gold or an alkene functional group. 
The thiocarbonylthio group terminated RAFT polymers can be converted to a thiol 
terminal by use of excess amine to act as a nucleophile,127 which allows for chemically 
attaching the thiol-terminated polymer on the gold surface due to high affinity of sulfur 
for gold.128,129 
R1 = CO2R, CONR’R”, OCOR, substituted aryl
R2 = Me or H
Polymerization
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1.4 Temperature responsive gold nanoparticles 
Temperature-responsive polymer modified gold nanoparticles have attracted 
significant attention in recent years for many versatile biomedical applications.130-134 
Unique optical properties of gold nanoparticles and conformational change of the 
surface bound responsive polymer producing observable optical property changes, 
which allows these hybrid material to use for biosensing and drug/gene delivery.  
In one example, gold nanoparticles coated with thermo-responsive pNIPAM shell has 
been developed as a colourimetric temperature and salt sensor by Hoogenboom and 
co-workers.135 A red coloured solution of citrate stabilized gold nanoparticle was 
obtained by the Turkevich method and pNIPAM was synthesized via RAFT 
polymerization. Different amount of salt was able to induce visible red to blue-purple 
colour change of the pNIPAM functionalised gold nanoparticles solution by particle 
aggregation at increased temperature, as shown in Figure 1.19. Furthermore, this 
particle shows higher temperature sensing regime in the presence of NaSCN compared 
to NaCl, indicating particle aggregation is not only due to charge screening, but also 
the Hofmeister effects. 
 
Figure 1.19 Schematic illustration of the synthesis of pNIPAM coated AuNPs and 
their thermo-responsive behaviour in aqueous solution and their aggregation in the 
presence of various concentrations of NaCl, figure adapted from reference 135. 
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Another example, Xia et al. has shown the novel drug cargo using thermal responsive 
pNIPAM copolymers by incorporating poly acrylamide (pAM) into pNIPAM polymer 
chain to control and release drug from gold nanocages.136 As shown in Figure 1.20, 
pNIPAM-co-pAM copolymers were grafted on surfaces of gold nanocages. On 
exposure to a near-infrared laser, the gold nanocages absorbed this light and the light 
energy was converted into heat. Thus, the heat triggered the collapsed globule 
structure of thermo-responsive polymer on gold nanocage surfaces and pre-loaded 
drugs release. After turning off the laser, the polymer chain conformation is relaxed 
and extended with the termination of drug release. Therefore, this smart polymer 
hybrid gold nanoparticles can be the potential solution for real biomedical applications 
such as hyperthermic cell/tissue treatment and drug delivery. 
 
 
Figure 1.20 Schematic representation and characterisation of the controlled-release 
system. A) Schematic illustrating how the system works, B) TEM images of pNIPAM-
co-pAM covered Au nanocages, figure adapted from reference 136. 
  
A B
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1.5 Carbohydrates 
A carbohydrate is a biological molecule performing many important roles in living 
organisms including energy source for metabolism, components of genetic molecule, 
immune system, fertilization, and preventing pathogenesis, etc.137 Carbohydrates are 
also referred to as ‘saccharide’ consisting of four chemical groups such as 
monosaccharides, disaccharides, oligosaccharides, and polysaccharides according to 
their degree of polymerization. Carbohydrates exist mostly as polysaccharides 
(glycans) in nature. On the cell surface, carbohydrates are covalently bonded to 
membrane proteins and lipids to form a dense glycocalyx mediating cell-cell 
interaction, recognition process, and cell-protection (Figure 1.21).138 
 
Figure 1.21 Electron microscopy image of a cross section of a rat myocardial capillary 
showing the glycocalyx of the endothelial cells, figure adapted from reference 138. 
 
Polysaccharides or oligosaccharides are highly complex macromolecules linked by 
single monosaccharide units together in variety of ways, this results in numerous 
glycan structural and chemical diversity of carbohydrates molecules.139 The most 
structural diversity comes from the differences of stereochemical configuration of 
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carbohydrate molecules such as enantiomers depending on the relative configuration 
by optical rotation (e.g. D/L-glucose), diastereoisomers depending on the 
configuration of one stereocenter that are also called epimers (e.g. glucose/galactose), 
anomers depending on the configuration of the anomeric carbon (/ ), different 
glycosidic linkages and branching between monomers (e.g. 1-4 / 1-6) as shown in 
Figure 1.22.139,140 
 
Figure 1.22 Isomerisation complexity of carbohydrates, the red colour indicates 
structural difference. 
 
Also, the complexity of glycans are determined by various combinations from several 
monosaccharide building blocks containing through linkage between multiple 
functional groups.141 Typically, mammalian glycans are composed of ten key 
mammalian monosaccharide units; glucose, galactose, mannose, N-acetyl 
glucosamine, N-acetyl galactosamine, fucose, xylose, glucuronic acid, iduronic acid 
and sialic acid which are able to assemble linear and branched structure (Figure 
1.23).139 These ten building blocks result in tremendous number of possible glycans 
with huge information density and very high degree of complexity due to many 
D-Glucose
180.16 g mol-1
Enantiomers
L-Glucose
180.16 g mol-1
Diastereoisomers
Glucose
180.16 g mol-1
Galactose
180.16 g mol-1
beta-Glucose
180.16 g mol-1
alpha-Glucose
180.16 g mol-1
Anomers Branching
Maltose
342.30 g mol-1
Isomaltose
342.30 g mol-1
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different combinational structures by stereochemical linkages between the functional 
groups of units compared to linear macromolecules like proteins and nucleic acids 
(DNA). Theoretically, the number of possible hexasaccharides generates more than 
1012 different structures, whereas the number of different hexamers of amino acids is 
calculated to 46656 structures.142,143 
 
Figure 1.23 The ten mammalian monosaccharides chemical structures with symbols 
are the CFG144 nomenclature, the red colour indicates structural difference from the 
glucose unit. 
  
Glucose Galactose Mannose
N-acetyl glucosamine N-acetyl galactosamine Fucose
Xylose Glucuronic acid Iduronic acid
Sialic acid (N-acetyl neuraminic acid)
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1.5.1 Protein-carbohydrates interaction: 
Multivalency in protein-carbohydrate 
interactions 
A carbohydrate is existed as glycans, glycosylated proteins, glycolipids on the cell 
membrane and it is able to interact with protein receptors such as enzymes or lectins.145 
This specific protein-carbohydrate interaction mediate signal transduction for many 
important physiological/biological events, including cell-cell communication, cellular 
proliferation, fertilisation, cancer metastasis, pathogen recognition process and cell-
microbe (bacterial, viral and bacterial toxin) adhesion, etc.146-151 
 
Figure 1.24 A schematic drawing illustrating protein-carbohydrate interactions at the 
cell surface mediating cell-cell binding, cell-microbe adhesion and cell-antibody 
binding, figure adapted from reference 152. 
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These interactions are typically so weak with a dissociation constant in the millimolar 
range (Kd = 10
-6 ~ 10-3 M) due to hydrogen bonds, van der Waals’ interactions and 
hydrophobic stacking between the carbohydrate and the protein.153 However, this 
recognition could be greatly enhanced by multivalent effect of densely packed 
carbohydrate molecules on the cell surface. The binding affinity of multiple 
carbohydrates is higher than the total sum of the individual carbohydrate binding, 
which is called as ‘glycocluster effect’.154-156  
This multivalent interaction is occurred through a variety of mechanisms; i) multiple 
carbohydrate residues within a glycan bind to corresponding oligomeric proteins on 
the cell surface or ii) secreted proteins, iii) a cluster of multiple glycans on the cell 
surface or iv) soluble glycans  bind to (cell surface/soluble) proteins. (Figure 
1.25).157-161 Furthermore, binding potency of multiple ligands can be enhanced by 
several manners such as chelation, subsite binding, clustering and statistical 
rebinding.162 
 
Figure 1.25 Carbohydrate-protein interactions. A) An oligomeric protein can interact 
with an individual cell-surface glycan or B) with multiple different cell-surface 
glycans simultaneously. C) Oligomeric proteins can also interact with soluble glycans 
or D) soluble oligomoeric lectins can interact with cell surface glycans. E) Soluble 
proteins can cluster cell-surface glycoproteins or F) soluble glycans can cluster cell-
surface receptors to mediate signal transduction, figure adapted from reference 161. 
A B C D
E F
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1.5.2 Lectins 
Lectins (from the Latin legere, ‘to select’) are carbohydrate-binding proteins playing 
a crucial role in many important biological activities as well as pathological processes 
for living organisms. They are ubiquitous, being found in animals, plants, 
microorganisms and also major components of the mammalian cells surface.163-165 A 
lectin usually contains two or more binding sites, or even some lectins form oligomeric 
structures with multiple binding sites which enables to interact with the carbohydrate 
through the specific non-covalently interaction (hydrogen bonding and electrostatic 
interactions). 
Legume lectins among plant lectins are the biggest family around 100 members have 
been isolated from plant seeds to investigate their binding characterisation. All legume 
lectins contain four invariant amino acid residues in the binding site for the protein-
carbohydrates interaction, such as asparagine, aspartic acid, glycine, and leucine or an 
aromatic amino acid.166 
The binding specificities of legume lectins have been well characterised. For example, 
concanavalin A (Con A) from the jack beans is the most popular legume lectin and 
used as a model system.167 Con A has a binding site in the each subunit of dimer 
structure at low pH (< 5.5) and tetramer structure at neutral pH that having high affinity 
with mannose and glucose. Another example, peanut agglutinin (PNA) from Arachis 
hypogaea has amino acids (Asp83, Gly104, Asn127 and Tyr125) that binding to 
conjugates of galactose/N-acetyl galactosamine (Gal1-3GalNAc) in the T-antigen as 
shown in Figure 1.26A.166 
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Several plant lectins are toxin, ricinus communis (ricin) is a toxin lectin isolated from 
castor beans and treated as a serious threat for use as a biological weapon. It is 
composed of the toxic portion of A chain and B chain for the cell-targeting (Figure 
1.26B). B chain of ricin binds to carbohydrates on the surface of cell due to its 
galactose specificity. The A chain penetrates through into the cytoplasm and cleaves 
an adenine residue from the 28S ribosome after disulphide linkage between the chains 
is broken, this leads to stopping protein synthesis by inactivation of ribosomes and 
ultimately killing the cell.168 
 
 
Figure 1.26 A) Schematic representation of the peanut agglutinin carbohydrate 
binding site figure adapted from reference 166, B) ricin with the toxic A chain (red), 
cell-targeting B chain and disulphide linkage (yellow), figure adapted from the 
reference 169. 
 
Lectins can be divided into various classes in terms of their amino acid sequences and 
biochemical properties. One large class is the C-type lectins requiring calcium ion.170 
Ca2+ (Mn2+, also a metallic cation) enhance the binding ability with carbohydrates by 
helping the positioning of amino acid residues in lectins. Animal C-type lectins have 
various subunits with 1-8 binding sites per each subunit and lectin folding has a 
Asp 83
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Ile 101
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Ser 211 Gly 213
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compact domain of 110 - 130 amino acids which are responsible for carbohydrate 
binding. As shown in Figure 1.27, a calcium ion directly links hydroxyl groups on the 
carbohydrate to amino acid residues in the protein, while other protein side chains 
form hydrogen bonding with other hydroxyl groups of carbohydrates.171,172 
Carbohydrate binding specificity can be altered by changes in the amino acid residues 
of the lectin. 
 
 
Figure 1.27 Structure of a C-type carbohydrate-binding domain from an animal lectin, 
figure adapted from reference 170. 
 
Bacteria also contain carbohydrate-specific lectins that enable bacterial adhesion onto 
host cell surface by molecular interaction between cell surface carbohydrates and 
lectins of bacteria.173 Particularly, bacteria produce surface lectins, commonly in the 
form of the fimbriae (or pili) that are hair-like assemblies of protein subunits and 
fimbriae are efficient adhesion tools to mediate colonization of various biotic and 
abiotic surfaces (Figure 1.28).174 
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Escherichia coli (E. coli) producing the type 1 fimbriae which are the most abundant 
structure both in pathogenic and non-pathogenic gram-negative bacteria. The FimH 
(type 1 fimbrial lectin) is mannose-specific and found at the tip of the fimbriae. The 
various bacterial surface lectins are able to initiate infectious diseases by mediating 
bacterial adhesion to epithelial cells in the urinary and gastrointestinal tracts thorough 
the specific and reversible non-covalently protein-carbohydrate interaction.175 
 
Figure 1.28 Electron micrograph of type 1 fimbriated E. coli., figure adapted from 
reference 174. 
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1.5.3 Anti-adhesion therapy 
Anti-adhesion therapy is an attractive approach for fighting bacterial infections. The 
adherent state is a key step for bacterial survival and one of the initial stages for the 
infectious process. Therefore, it is very important to interfere the adhesion at an early 
stage following the exposure of the host to pathogens. Anti-adhesion method employs 
competitive inhibition agents that reduce ability of contact between host cells and 
pathogens. Carbohydrate or its analogues which are structurally similar to 
glycoprotein or glycolipid receptors for the adhesion bind the bacteria primarily, rather 
than the carbohydrates on the host cell in the competitive inhibition process.176 The 
anti-adhesion strategy inhibits pathogenicity by interference agents rather than kill or 
arrest growth of the pathogen like antibiotics, this leads to significantly lower bacteria 
resistant to the anti-adhesion agent than bacteria resistant to antibiotics. Also, this 
agent do not disrupt normal microbiota within the organism. 
 
 
Figure 1.29 Schematic illustration of anti-adhesion therapy: inhibition of microbial 
adhesion using anti-adhesion agents (e.g. glyco-ligands). 
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Some drawbacks of anti-adhesion therapy are that pathogens express more than one 
type of adhesion during the infectious process due to their various adhesion encoding 
genes and low binding affinity of the carbohydrate for the proteins on the bacteria.176 
For an effective anti-adhesion therapy, multiple agents are required to inhibit each type 
of adhesion of the infecting pathogen or inhibitors should exhibit a broad range of anti-
adhesion activity as well as high binding affinity for target pathogens.177 
The use of synthetic oligosaccharides as multivalent adhesion inhibitors have been 
developed by attaching many copies of the saccharides, to increase the low binding 
affinities of monovalent glycoside.178 Synthetic glycopolymers have also been 
exploited by functionalisation with terminal carbohydrates and linking branches with 
functional residues for effective inhibition of adhesion. Some examples demonstrated 
glycopolymer were successfully used as specific inhibitors for cholera toxin binding179 
and fimbriated strains of E. coli binding.180 
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1.6 Glycopolymers 
Synthetic glycopolymers mimicking natural biomolecules have been extensively 
investigated for medical applications due to ease of synthesis, variable structure and 
chain length. Pendant sugar moieties along the polymer backbone or at the end of the 
chain are able to interact with target proteins through multivalent interactions.181-183 
The strength of binding strongly relies on the type of sugars, anomeric status, 
connecting linker type and linkage position between the carbohydrate and the polymer 
backbone, density of sugars, degree of polymerization and branching.161,184 Therefore, 
the design of the glycopolymer for multivalent presentation (specific carbohydrate-
protein interactions) is very important and essential. For example, glycopolymers can 
access to multiple binding sites in proteins by increasing the polymer chain length and 
hence increasing their binding affinity. 
 
1.6.1 Glycopolymers: post-polymerization 
modification 
Especially, glycopolymers have been successfully synthesized using post-
polymerization modification processes, Figure 1.30. This method is a highly attractive 
for synthesis of functional polymers that can overcome the limited functional group 
tolerance compared to direct polymerization using controlled polymerization 
techniques. Monomers bearing functional groups that are inert to the polymerization 
conditions but able to introduce additional functionality. These monomers were 
polymerized directly through the controlled polymerization to generate reactive 
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polymer precursors still containing side-chain functionalities (chemoselective 
handles). Then in a subsequent step, polymer precursors converted into desired 
functional polymers with a broad range of bifunctional reagents.  
The identical reactive polymer precursor results in diverse libraries of different 
functional polymers with same molecular weight and chain-length distribution by 
post-polymerization modification and this strategy is very useful to probe structure-
property relationships of polymer.185 
 
Figure 1.30 Synthesis of functional polymers by post-polymerization modification. 
 
Bifunctional reagents
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RAFT polymerization has been used to synthesis poly(pentafluorophenyl 
methacrylate) (pPFMA) backbones as reactive scaffolds for further functional 
modification with primary amines by Gibson et al.186 Diverse libraries of functional 
polymers with same chain length distribution were prepared from the same starting 
polymer precursor via post-polymerization modification to determine structure-
property relationships.186 In order to obtain the bio functionality for glycopolymers, 
the pPFMA scaffolds were functionalised with allylamine to generate pendant alkene 
functionality, and then alkene/alkyne side chains were subsequently functionalised 
with thiolated carbohydrates in sequential addition procedure via thiol-ene ‘click’ 
chemistry187,188 which describes highly efficient coupling reactions that proceed to 
quantitative conversion without any side products by Sharpless (Figure 1.31).189 
 
 
Figure 1.31 Schematic of glycopolymers by post-polymerization modification from 
‘clickable’ structure. 
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1.6.2 Glycopolymers for bacteria and lectin 
treatments (bio applications) 
In order to achieve and enhance the specific recognition of lectins from pathogens, 
bacteria and cancer cells, numerous investigations using glycopolymers have been 
focused. Various types of glycopolymers with carbohydrate moieties along the 
polymer backbone or at the end of the chain for mimicking natural biomolecules could 
be prepared by synthetic polymeric techniques including post-polymerization 
modification. 
Polizzotti et al. and co-workers designed glycopolymers as an anti-adhesion agents to 
act against infections by the cholera toxin (CT), Shiga toxins, and the heat-labile 
enterotoxin (LT). Poly(L-glutamic acid) (PGA) backbone incorporated with different 
degrees of -D-galactosylamine was obtained by post-polymerization modification. 
The binding of galactose-functionalised glycopolymers to bacterial toxins is improved 
due to higher accessibility of galactose as increasing the bearing proportion 
(composition) of functional carbohydrate moiety in polymer.190,191 
Glycoconjugate polymers having oligosaccharides and amino group were synthesized 
to perform as Shiga toxins (Stx1 and Stx2) adsorbents by Hatanaka group. 
Glycopolymers bearing globotriose/lactose units and small amount of acrylamide 
exhibited inhibitory effects on cytotoxicity of Stx1 and Stx2, respectively.192 
Haddleton et al synthesized a library of glycopolymers containing mannose and 
demonstrated that mannose in clustered polymeric structure showing the high-affinity 
binding to a human dendritic cell associated lectin (DC-SIGN) related to immune 
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responses. This simple structures effectively prevented interactions between the DC-
SIGN and the human immunodeficiency virus (HIV) envelope glycoprotein gp120 as 
shown in Figure 1.32.193 
 
Figure 1.32 Schematic design of evaluating mannose and galactose functional 
polymers for DC-SIGN binding, figure adapted from reference 193. 
 
Specific carbohydrates functionalised glycopolymers allow the potential sensing of a 
range of pathogens. Seeberger group used a water soluble fluorescent-conjugated 
glycopolymer to allow for multivalent detection of pathogens.194 Poly(p-phenylene 
ethynylene) (PPE) was functionalised with mannosides by post-polymerization 
modification method. After incubation of the polymers with E. coli, brightly 
fluorescent cell clusters were shown due to multivalent interactions between the 
mannosylated glycopolymer and mannose receptors on the bacterial pili, which was 
confirmed by microscopy. 
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Glycopolymers can also be used as drug delivery systems. Suriano et al. have 
synthesized a family of amphiphilic block glycopolymers bearing D-glucose, D-
galactose and D-mannose. Carbohydrates-bearing glycopolymers were able to self-
assemble into micelles having a high density of sugar molecules in the shell with 
particle size of 100 nm and narrow size distribution, even after drug loading. 
Especially, galactose-containing micelles efficiently delivered doxorubicin (a drug 
used for liver cancer treatment) into targeted human liver hepatocellular carcinoma 
cells (HepG2) thorough interactions of galactose and the asialoglycoprotein receptors 
(ASGP-R) on the surface of hepatocytes.195 
The results of these studies suggest strategies for optimising the binding of linear 
glycopolymers to bacterial toxins (protein-based materials). It is important to mention 
that the design of glycolpolymer structure in terms of molecular weight, multivalency 
of carbohydrate, spacing, linker length, branching and backbone rigidity can have a 
critical impact in a variety of biologically relevant (binding) events. 
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1.6.3 Glyconanoparticles for bacteria and lectin 
detection 
Glyconanoparticles based on gold as a core metal have been extensively investigated 
as a part of biosensor systems due to their high stabilization, easy modification in size 
and composition, electronic and optical properties. Thiol-functionalised glycopolymer 
or saccharides (via RAFT polymerization) were efficiently attached onto gold 
nanoparticles and this particle demonstrated that the detection of some toxic lectins 
from other previous works successfully. Also, glyconanoparticles can mimic a 
globular shape of glycocalyx like shell to understand better than the functions of 
carbohydrates on the cell surface. 
Penadés group first presented gold glyconanoparticles in 2001.196 The thiol-ended 
disaccharide lactose or the trisaccharide were directly immobilized on gold 
nanoparticles surface. Gold salts (AuCl4
-) were reduced in the presence of the desired 
thiol-functionalised glycoploymers with reducing agent (NaBH4) through one-step 
preparation. In their another work, glyconanoparticles were obtained by multi-steps, 
gold nanoparticles were previously prepared by reducing gold salts (HAuCl4), and 
then excess of thiol-armed carbohydrate derivatives were conjugated with gold 
nanoparticles in the subsequent step.197 
Narain et al. reported biotinylated gold nanoparticles from well-defined biotinylated 
glycopolymers, pNIPAM, poly(ethylene glycol) (PEG), and HAuCl4 via a 
photochemical process. Multifunctional biotinylated glyconanoparticles underwent 
aggregation in the presence of the streptavidin due to the biotin-streptavidin 
interaction. These particles showed a high colloidal stability and high affinity for 
44 
 
bioconjugation to streptavidin, which are evaluated from surface plasmon resonance 
(SPR) curves by UV-vis spectroscopy.198 
 
 
Figure 1.33 Schematic representation of the preparation of multifunctional 
biotinylated glyconanoparticles via a photochemical process, figure adapted from 
reference 198. 
 
Furthermore, many researchers have recently developed efficiency of colourimetric 
sensing of toxic lectins by optimising various conditions such as length of the linker 
and polymer backbone, the density of ligands and size of core gold nanoparticles. 
The influence of carbohydrate density on selective gold nanoparticles aggregation was 
investigated by Otsuka et al.199 Lactose-conjugated gold nanoparticles exhibited 
selective aggregation when exposed to a bivalent lectin Ricinus communis agglutinin 
120 (RCA120), inducing significant changes in the absorption spectrum with visible 
colour change from red to purple. Further, more than 20 % lactose was required for 
aggregation to occur and the degree of aggregation was proportional to lectin 
concentration. 
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Lin et al. demonstrated that the multivalent interactions between mannose 
encapsulated gold nanoparticles and lectins/bacteria were affected by core particle size 
and the linker of ligands. The 20nm size gold nanoparticles with short 
mannopyranoside linker length showed the highest affinity to Con A as determined by 
SPR response curves200 and 6 nm sized gold nanoparticles selectively bound to the 
mannose adhesion FimH of bacterial type 1 fimbriae, was observed by transmission 
electron microscopy (TEM).201 
Richards et al. developed and optimised a versatile method to produce 
glyconanoparticles for lectins and lectin-expressing bacteria detection. Gold 
nanoparticles functionalised with galactose and mannose-ended poly(ethylene glycol)  
(PEG) discriminated between different strains of E. coli based on their different 
expression levels of the FimH adhesion. The use of the PEG chain increases the 
colloidal stability of particles retaining their bio-recognition properties. The optical 
properties of nanoparticles rapidly changed when bind to protein FimH positive 
bacteria, enabling the identification of bacteria strain by both the UV-absorbance peak 
and the visible colour shits.202 
 
Figure 1.34 Schematic representation of carbohydrate-functionalised gold 
nanoparticles for selective binding to different strains of bacteria, figure adapted from 
reference 202. 
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In another work, glycosylated poly(hydroxyethyl acrylamides) (pHEA) with different 
degree of polymerization (DP) were immobilized onto 60 nm gold nanoparticles to 
evaluate the influence of glycopolymer chain length.203 It is noted that long 
glycopolymer chain with a DP above 50 improved saline stability of particles, but 
particles were unable to generate a response upon addition of the lectins due to steric 
stabilization. Through an optimisation study, it was found that mixture of short 
glycopolymers with DP10 and DP20 gave rise to stable particles with rapid 
colourimetric response resulting from glyconanoparticle aggregation induced by 
correct lectins. 
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1.7 Polymer grafting density 
The number of bound polymers per unit surface area (i.e. the grafting density) is a key 
parameter for design of nanoparticles in biological applications. This parameter 
directly affects the hydrodynamic diameter, colloidal stability of nanoparticles and 
drug loading capacity in the case of functionalised polymer incorporating drugs or 
sugars at the chain end.204-207 
In general, thermogravimetric analysis (TGA) is a widely used tool for quantitative 
analysis of polymer grafting density and grafting density can be experimentally 
estimated from TGA of the carbon content in a solid nanoparticle-polymer sample. 
The grafting density (TGA) of polymer on the surface of gold nanoparticle can be 
calculated from TGA analysis using following equation 1.208 
𝜎𝑇𝐺𝐴 =
𝑤𝑡%𝑠ℎ𝑒𝑙𝑙
𝑤𝑡%𝑐𝑜𝑟𝑒
𝜌𝑐𝑜𝑟𝑒
4
3 𝜋𝑟
3
𝑐𝑜𝑟𝑒𝑁𝐴
𝑀𝑊𝑝𝑜𝑙𝑦𝑚𝑒𝑟4𝜋𝑟2𝑐𝑜𝑟𝑒
       (1) 
First, the relative mass of the polymer (wt%shell) and the residual mass of the total core 
gold particle (wt%core) are found form the TGA data. The number of polymer units per 
total sample is then derived by taking the polymer mass (wt%shell) and dividing by the 
polymer mass per chain (i.e. polymer molecular weight / avogadro’s number). The 
total particle surface area in the sample is defined to be the total number of particles 
multipled by the surface area per particle (4r2). The number of nanoparticles is 
derived from the total core gold particle mass (wt%core) divided by the single core gold 
particle mass, which corresponded to the volume of a single particle (4/3r3) and the 
density of bulk gold (core = 19.6 g cm-3). It is important to note that the radius of 
particle can be measured from TEM and both the surface area and volume calculations 
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require the assumption that the particle has a perfect spherical shape. 
Gibson et al. estimated grafting density of thermo-responsive polymer 
poly(poly(ethylene glycol)methacrylate) (PPEGMA) coated gold nanoparticles from 
TGA measurement.209 They assumed all particles have a grafting density of 0.3 chains 
of PPEGMA per nm2 of gold particle surface. However, conventional TGA method 
requires a large amount of dried sample in order to provide sufficient quantity for 
analysis (i.e. milligrams). 
For some polymers, X-ray photoelectron spectroscopy (XPS) can effectively measure 
the particle surface coverage of polymer. Ieong et al. calculated the relative grafting 
density (rather than the absolute) from the relative elemental compositions and MW 
information of polymer (equation 2) due to the penetration depth of the X-rays is 
estimated to be ~ 10 nm only.210 Both longer poly(N-vinylpyrrolidone) (PVP) and 
poly(oligo(ethylene glycol)methacrylate) (POEGMA) had relatively lower grafting 
densities due to the increased steric hindrance of polymers, as shown in Figure 1.35. 
Relative grafting density =  
𝐼𝐶(𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑐𝑎𝑟𝑏𝑜𝑛 𝑠𝑖𝑔𝑛𝑎𝑙𝑠)
𝑁𝑢𝑚𝑏𝑒𝑟 𝐶𝑎𝑟𝑏𝑜𝑛𝑠 𝑖𝑛 𝑀𝑜𝑛𝑜𝑚𝑒𝑟 × 𝐷𝑃 
       (2) 
 
Figure 1.35 Schematic comparing different grafting densities of polymers on particle 
surface as a function of polymer chain length and monomer type containing small side 
chain (PVP) / large (POEGMA), figure adapted from reference 210. 
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1.8 Aims and thesis summary 
Considering above, this thesis aimed to achieve two main targets: firstly the 
investigation of temperature responsive behaviour and co-operative behaviour for 
fine-tuning the transition temperature of thermo-responsive polymer tethered gold 
nanoparticles. The second aim was the development of a colourimetric detection 
method to probe protein-carbohydrate and carbohydrate-carbohydrate interactions 
based on stimuli response multivalent glyconanoparticles. 
Chapter2 describes the fine-tuning of transition temperatures by blends of pNIPAM 
coated gold nanoparticles. pNIPAM with a thiol-functional terminal group was 
synthesized via RAFT polymerization and thermo-responsive gold nanoparticles were 
prepared by polymer grafting onto particle surface. Versitile approches were shown to 
mix nanoparticle components for co-operative thermal transitions; i) different 
polymers on same sized particles, ii) mixture of polymers on same sized particles, iii) 
same polymer on different sized particles and iv) different polymers on different sized 
particles. This provided precise control over the transitions of the responsive 
nanomaterials. 
Chapter 3 develops a novel stimuli-responsive multifunctional gold nanomaterials as 
a colourimetric biosensor. Functional polymer tethered gold nanoparticles enabled 
temperature switchable target lectin detection based on combining the bio molecular 
recognition of galactose modified pHEA and the thermo-sensitivity based on the coil-
to-globule phase transition of pNIPAM as a blocking agent. In order to increase 
sensitivity and selectivity for the rapid detection of lectins, several key conditions were 
optimised such as core particle size, blocking agent chain length and proportion 
between two different polymers. It was possible to achieve a smart polymer/gold 
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nanoparticle biosensor possesses temperature responsive phase transition and specific 
targeting multifunctional behaviour simultaneously. 
Finally, Chapter 4 shows an extended study that the previous methodology with larger 
glycans and the same polymers can used to demonstrate that larger sugar structures do 
not perturb the function of the thermo-responsive polymer or the efficient masking of 
the glycans. Multivalent glyco-nanostructures where the surface-expression of lactose 
can be triggered by an external stimulus, and a gold nanoparticle core enables 
colourimetric signal outputs to probe binding. Two different carbohydrate-
carbohydrate interactions were investigated using this tool, which will enable their 
exploitation in biotechnology. 
Chapter 5 is a conclusion chapter. 
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Chapter 2 
2. Co-operative Transitions of Responsive-
Polymer Coated Gold Nanoparticles; 
Precision Tuning and Direct Evidence for 
Co-operative Aggregation 
 
2.1 Chapter summary 
In this chapter, the thermal properties of the pNIPAM polymer with various molecular 
weights and salt effect on LCST of the polymer will be described first, and then the 
characterisation and thermal aggregation behaviour of gold nanoparticles conjugated 
with these polymers will be reported. 
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2.2 Abstract 
Responsive polymers and polymer-coated nanoparticles have many potential 
applications with the crucial parameter being the exact temperature where the 
transition occurs. Chemical modification of hydrophobic/hydrophilic or ligand 
binding sites has been widely explored. This study reports an extensive investigation 
into the use of blending as a powerful tool to modulate poly(N-isopropylacrylamide) 
(pNIPAM) coated gold nanoparticles. By simply mixing nanoparticles of different 
compositions precise control over the transition temperature can be imposed. This was 
shown to be flexible to all possible mixing parameters (different polymers on different 
particles, different polymers on same particles and different sized particles with 
identical/different polymers). For the first time, direct evidence of the co-operative 
aggregation of differently sized nanoparticles (with different cloud points) is shown 
using transmission electron microscopy; particles with higher cloud points 
preferentially aggregate with those with lower cloud points with homo-aggregates not 
seen, unequivocally demonstrating the co-operative behaviour. 
 
2.3 Introduction 
Stimuli-responsive polymers can change their conformation and exhibit their 
properties when external stimuli, such as temperature,1 pH,2 light,3 ions,4 electric,5,6 
magnetic field7 and biochemical agents8 are applied. These unique properties and 
abilities have been formulated with polymers for various biomedical fields in a number 
of forms including simple polymer solutions,9 hydrogels,10,11 micelles,12 films and 
layers.13,14 Especially, thermo-responsive polymers are the most commonly used for 
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both in vitro15-18 and in vivo19-21 biomedical applications. Thermo-responsive polymers 
in solution display a lower critical solution temperature (LCST) or upper critical 
solution temperature (UCST). The LCST is the point where the polymer phase 
separates such that the polymer solution is miscible below the critical temperature 
whereas polymer solution is immiscible (precipitates) above it. 
Poly(N-isopropylacrylamide) (pNIPAM) is one of the most well-known temperature-
responsive polymers.22-24 The mechanism of pNIPAM phase transition has been 
studied from many research groups and the most possible theory of temperature 
dependent phase transition is hydrogen-bonding interactions between pNIPAM and 
water.25-28 In general, the LCST transition of pNIPAM is exhibited from 30 °C to 
45 °C.29-32 Several factors including molecular weight of polymer,33 terminal group of 
polymer,34 polymer concentration,35 pH in solution and the presence of salt36 as well 
as self assembly37 have significant effects on the observed transition temperatures. 
By employing reversible addition fragmentation and transfer (RAFT) polymerization, 
pNIPAM (and indeed many other classes of polymers) can be directly incorporated 
onto the surface of gold nanoparticles due to the quantitative installation of a (masked) 
thiol at each -chain end. Responsive polymer coated gold nanoparticles retain 
sensitivity to external stimuli38-40 and can be applied in wide range of therapeutic 
applications including a catalysis, diagnosis, imaging and photoelectronic device.41-47 
It has been reported that pNIPAM coated gold nanoparticles can be used to drive 
cellular uptake upon increasing the temperature above the solution temperature due to 
a shift in the lipophilicity of the particle promoting membrane interactions46,48 and is 
an attract route to gain entry into cells for delivery applications. However, to achieve 
this (or other) goals, precise control over the transition temperature is essential. It has 
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been reported by Fernández-Trillo et al that the cloud point of elastin-mimetic 
polymers could be tuned by simple mixing polymers with different cloud points.49,50 
This has been shown to be the case for some polymers but also polymer-grafted 
nanoparticles.51,52 However, other classes of polymers failed to show any cooperativity 
with distinct ‘steps’ seen in mixtures of polymers such as elastin peptides or 
poly(oligo[ethyleneglycol methacrylates]).53 
This raises questions about the scope of the blending approach but also the mechanism 
– for a single transition to occur, the particle/polymer with the higher cloud point must 
preferentially interact with the particle/polymer with a lower cloud point (otherwise it 
would not aggregate at temperatures below its own transition temperature). This 
implies a more complex inter-relationship between the entities than is often considered, 
and thus far there is no direct evidence of these interactions, as only turbidimetry is 
employed.  
In this study, the co-operative aggregation of pNIPAM coated nanoparticles is studied 
in detail and the limits and scope of the blending (using all possible mixing parameters 
of particles and polymers) is studied using a range of techniques. Crucially, the size-
dependant co-operative transitions are studied using electron microscopy, enabling the 
identity of each interacting component to be assigned to direct observe the 
cooperativity for the first time. 
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2.4 Result and Discussion 
To access the range of well-defined pNIPAM’s required for this study RAFT 
(reversible addition fragmentation chain transfer) polymerization was employed, 
Scheme 2.5A. It is curcial to select appropriate RAFT agents for a successful RAFT 
polymerization. Monomer (meth)acrylamides is classified in ‘more activated’ 
monomers (MAMs) which have their vinyl group conjugated to a carbonyl group and 
produce more stabilized radicals. A Z-group of the RAFT agent should help with the 
stabilization of the intermediate radical from monomers and promote the reactivity of 
the C=S bond toward radical addition.54 Therefore, a trithiocarbonate (Z = S-alkyl) 
RAFT agent was chosen, and synthesized, based on its reported utility for control over 
the RAFT polymerization of NIPAM, which also inserts the desired thiol end-group 
and carboxyl acid at the each - and - end of polymer for later immobilization onto 
gold nanoparticles and particle colloidal stabilities. Furthermore, this RAFT agent can 
be mass-produced and commercially purchased with low cost. The acid functionalised 
2-(dodecylthiocarbonothioylthio)-2-methylpropanoic acid RAFT agent was 
characterised by 1H NMR, 13C NMR and Fourier transform infrared (FT-IR) spectra. 
 
Figure 2.1 1H NMR spectra of 2-(dodecylthiocarbonothioylthio)-2-methylpropanoic 
acid in CDCl3. *=solvent 
RAFT AGENT H NMR.ESP
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
0.090.530.220.06
*
73 
 
 
Figure 2.2 13C NMR spectra of 2-(dodecylthiocarbonothioylthio)-2-methylpropanoic 
acid in CDCl3. *=solvent 
 
 
Figure 2.3 Infrared spectra of 2-(dodecylthiocarbonothioylthio)-2-methylpropanoic 
acid. IR cm-1: 2917 (alkyl-H stretch); 1712 (C=O stretch); 1070(S-(C=S)-S stretch). 
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Three different molecular weight of NIPAM were polymerized in an optimal condition 
(methanol/toluene solution system at 70 oC) for a higher radical generation rate and 
polymerization rate with a narrow degree of polymerization (DP). The number of 
living and dead products polymer chain can be calculated from the number of RAFT 
agent moieties and the number of radicals generated from the initiator.54 From the 
RAFT agent : initiator feed ratio (10 : 2), two radicals are introduced in a system 
containing ten RAFT agents, this leads to twelve chains comprising ten living chains 
and two dead chains by assuming the disproportionation termination. Therefore, our 
system has L (% of livingness) = 10/(10 + 2) × 100 = 83 % of living polymer with the 
trithiocarbonate end-group at the -end. It is noteworthy that using lower amounts of 
initiator is more effective way to reach much higher conversion of polymer. 
Isolated polymer precipitates were characterised by 1H NMR spectroscopy and size 
exclusion chromatography (SEC). The resonance peaks related to the methine proton 
of N-isopropyl group are observed at 4.0 ppm as shown in Figure 2.4, along with those 
associated with the C12 end group at 1.2 ppm. 
 
 
Figure 2.4 1H NMR spectra of poly(N-isopropylacrylamide) with DP100. 
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SEC confirmed a controlled polymerization with narrow dispersity values and the 
observed molecular weights agreeing well with those predicted from the monomer : 
initiator feed ratio, conversion was calculated by 1H NMR spectrum with reference to 
a mesitylene standard and each sample was found to have more than 70 % conversion. 
The polymers are labelled from here based on their targeted degree of polymerization; 
pNIPAM25, pNIPAM50 and pNIPAM100 as shown in Table 2.1 and Figure 2.5B. 
 
Figure 2.5 A) Synthetic route to pNIPAMs; B) SEC analysis of polymers. 
 
Table 2.1 Characterisation of polymers. 
Polymer [M]/[CTA]/[I] 
[mol] 
Mn Target  
[g mol-1] 
Conversiona) 
[%] 
Mn Theo  
[g mol-1]b) 
Mn SEC  
[g mol-1]c) 
Mw / Mn 
[-] 
pNIPAM25 25/1/0.2 2800 87 % 2500 2900 1.07 
pNIPAM50 50/1/0.2 5700 84 % 4800 4900 1.07 
pNIPAM100 100/1/0.2 11300 72 % 8100 7700 1.10 
pNIPAMxxx = poly(N-isopropylacrylamide) where average degree of polymerization 
indicated by xxx.; a)Determined 1H NMR; b)Calculated from the [monomer]:[CTA] 
ratio and of conversion; c)Determined by SEC in DMF using 
poly(methylmethacrylrate) PMMA standards. 
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The polymers were then evaluated for their thermo-responsive behaviour both in water 
and in phosphate buffered saline (PBS), as this is crucial for the measurements later in 
this study. ‘Grafted to’ gold nanoparticle polymer hybrids require salt to screen their 
overall net negative charge (vide infra).55 UV-Vis spectroscopy was used to determine 
the cloud point (CP) of polymer defined as being the point of 50 % transmittance and 
the results of this (at 2.5 mg mL-1) are shown in Figure 2.6 and Table 2.2. (Note, the 
cloud point is distinct from, and is the macroscopic effect associated with, an LCST). 
In water the polymers all had CPs close to the expected 32 °C (Figure 2.6A), but in 
buffer an unexpectedly high cloud point was observed with the shortest polymer 
having a transition above 60 °C as shown in Figure 2.6B. Previous work on pNIPAM 
(and indeed most thermo-responsive polymers) has shown that shorter polymers tend 
to have a higher cloud point, but saline normally depresses this value.56-58 We ascribed 
this to partial self assembly of the shortest polymers into micelles due to the 
hydrophobic end group, and hence the transitions are for nanostructures (e.g. micelles) 
rather than the polymers with the C12 acting as the hydrophobic core. This effect has 
been observed by O’Reilly and co-workers showing that C12 end-groups can 
essentially function as a second hydrophobic block.59 Once a micelle, the LCST will 
change due to conferment effects in the corona.37,60,61 As the key aim of this work was 
to investigate the co-operative behaviours of gold nanoparticle (AuNP) hybrid 
materials, where the end group effects become less signficant, this was not explored 
any further. 
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Figure 2.6 Turbidimetry scans (absorbance at 700 nm) of homopolymer in A) pure 
water and B) PBS. In all cases the total polymer concentration of the solutions was 2.5 
mg mL-1. 
 
As the key aim of this study is to assess the co-operative CP transitions of hybrid 
nanoparticles, the co-operative aggregation of mixtures of these nanoparticles were 
studied. To observe this co-operative property, a pair of polymers having different 
molecular weights below ~10 kg mol-1 were tested as pNIPAM does not have a strong 
molecular weight dependence on its LCST above this value.57,62 pNIPAM50 (4.9 KDa) 
and pNIPAM100 (7.7 KDa) were prepared at 2.5 mg mL
-1 in PBS solution. Table 2.2 
and Figure 2.7 also show transition temperature for blends of pNIPAM50 and 
pNIPAM100 at various weight fraction compositions. There are two independent 
transition temperature of each pure polymer, pNIPAM50 has a transition temperature 
of 47 °C whereas pNIPAM100 has a transition temperature of 41 °C. Blends of these 
polymers at all weight fractions shows a clear transition between 41 - 47 °C. The CPs 
of polymer mixture were shifted towards higher as increasing amounts of pNIPAM50 
to pNIPAM100 with a cloud point of 42 °C, 43 °C and 45 °C, respectively. Previous 
reports on the shorter pNIPAMs showed that blends of these polymers underwent a 
single transition, based on the average molecular weight (MW) of the blend, but that 
longer polymers, or those with a great difference between their CPs had multiple 
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transitions.52 This is in agreement with what was seen here, but with some shifting of 
the cloud point, albeit with two steps in the transition by the partial self assembled 
nanostructures transtion rather than the polymers due to incorporated hydrophobic end 
group. 
Table 2.2 LCST values for each polymer and polymer mixture in different media. 
Polymer Weight Fraction 
[%] 
Cloud pointwater  
[°C]a) 
Cloud pointPBS  
[°C]b) 
pNIPAM25 100 33 61 
pNIPAM50 100 36 47 
pNIPAM100 100 38 41 
pNIPAM50 : pNIPAM100 25 : 75 - 42 
pNIPAM50 : pNIPAM100 50 : 50 - 43 
pNIPAM50 : pNIPAM100 75 : 25 - 45 
Cloud point was measured in a)pure water and b)PBS buffer upon heating from 25 °C 
to 85 °C, 2.5 mg mL-1 polymer concentration. CPs of pNIPAM mixture were not 
measured in water due to the very narrow gap between each polymers CP. 
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Figure 2.7 Turbidimetry analysis of blends of pNIPAM50 and pNIPAM100 in PBS 
buffer at 2.5 mg mL-1. 
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With the function of the polymers and their co-operative nature confirmed, pNIPAM 
coated gold nanoparticles were synthesized as shown in Scheme 2.1. Terminal thiol 
functionality of pNIPAM can be prepared by nucleophilic cleavage of the 
trithiocarbonate end-group using nucleophiles (e.g. amines, thiols, hydroxide).63-65 
Briefly, thiol-terminated RAFT polymers were mixed onto pre-made citrate stabilized 
gold nanoparticles (15 nm and 40 nm) by a simple mixture procedure, which we have 
used previously. Excess polymer was removed by repeated centrifugation of samples 
to ensure only polymer-coated nanoparticles were investigated and not free polymer. 
 
Scheme 2.1 Synthesis of thermo-responsive polymer (pNIPAM) and polymer/gold 
hybrid nanoparticles. 
 
The nanoparticles were characterised by a range of techniques including transmission 
electron microscopy (TEM), dynamic light scattering (DLS) and X-ray photoelectron 
spectroscopy (XPS). The hydrodynamic diameter of uncoated gold nanoparticles was 
17.5 nm and 42.4 nm by DLS measurements while after pNIPAM coating diameter 
were increased to 37.2 nm and 60.7 nm, respectively confirming the surface-tethering 
of the polymer chains. The surface plasmon resonance bands were also red shifted to 
longer wavelengths from 520 to 525 nm for 15 nm of gold nanoparticles and 526 to 
or
Centrifuge/Wash Re-suspend
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531 nm for 40 nm of gold nanoparticles consistent with successful functionalisation 
as shown in Table 2.3 and Figure 2.8. 
Table 2.3 Characterisation of the polymer coated nanoparticles. 
Particle a) SPRmax  
[nm] 
dDLS  
[nm] b) 
Cloud point [°C]c) 
Bare Au 15nm 520 17.5 - 
pNIPAM25@Au15 524 24.1 - 
pNIPAM50@Au15 524 32.3 74 
pNIPAM100@Au15 525 37.2 55 
Bare Au 40 nm 526 42.4 - 
pNIPAM25@Au40 530 49.6 - 
pNIPAM50@Au40 531 55.5 80 
pNIPAM100@Au40 531 60.7 60 
a)X@Aum: X = polymer coating used; m=diameter of gold nanoparticle; 
b)dDLS(nm): 
Z-average diameter as determined by DLS; c)measured in PBS upon heating from 
25 °C to 85 °C, 0.029 mg mL-1 total gold concentration. 
 
 
Figure 2.8 Size characterisation of pNIPAM100@Au15 and pNIPAM100@Au40 
nanoparticles. A + B) UV-Vis analysis before and after polymer coating; C + D) DLS 
analysis before and after polymer coating. 
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The particles were also imaged by TEM after functionalization with the polymers (the 
non-coated polymers tended to aggregate on the TEM grid, see Figure 2.9). A uniform 
distribution of spherical core nanoparticles with an average particle size of 15.2 ± 1.4 
nm and 40.7 ± 4.0 nm were observed in TEM and there was no evidence of 
agglomeration or ripening of the gold supporting the conclusion that the polymers 
were coating the gold particles. 
 
 
Figure 2.9 TEM images of gold nanoparticles. A + B) 15nm and C + D) 40 nm sized 
gold nanoparticles before and after pNIPAM100 coating. Polymer functionalised 
particles showing higher colloidal stability. 
 
A B
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Chemical characterisation was conducted using surface X-ray photoelectron 
spectroscopy (XPS) using gold particles deposited on silicon supports. As can be seen 
in Figure 2.10 and Table 2.4, both carbon (C1s) and nitrogen (N1s) region (at around 
400.0 eV) of the spectra for the pNIPAM coated gold nanoparticles is broader than the 
bare gold nanoparticles. This is due to the C - N peak at around 286.0 eV. The presence 
of the C = O peak at around 288.0 eV indicates clear evidence of the presence of 
pNIPAM on the gold surface. Also, the intensity of both carbon and nitrogen peak 
increased higher after conjugation of longer pNIPAM polymer chain because of the 
higher concentration of carbon and nitrogen are incorporated in longer pNIPAM chain. 
Furthermore, the XPS elemental ratio result could be used to calculate remaining 
citrate ligands at surface of gold nanoparticle after polymer coating. The C : O ratio of 
citrate stabilised bare gold nanoparticle is almost equal (Table 2.4) in agreement with 
theoretical 1 : 1 ratio due to trisodium citrate has 7 carbon and 7 oxygen. In the case 
of pNIPAM coated on gold nanoparticle surface, the C : N ratio should be 
approximately 6 : 1 (NIPAM monomer has 6 carbon and 1 nitrogen), if there is no 
residual citrate on particles surface after polymer grafting. However, the actual C : N 
ratios of three different pNIPAM coated nanoparticles were 15 : 1 – 20 : 1 rather than 
6 : 1 as shown in Table 2.4, this result clearly indicated that the gold nanoparticle 
surface still has citrate residues in the presence of pNIPAM with similar ratio between 
pNIPAM and citrate. 
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Figure 2.10 X-ray photoelectron spectroscopy analysis of pNIPAM functionalised 
gold nanoparticles. Representative high-resolution XPS spectrum of C 1s and N 1s 
region before and after various pNIPAM conjugation. A) Carbon (C 1s) peak and B) 
Nitrogen (N 1s) peak from the XPS analysis of polymer/gold hybrid nanoparticles 
(normalised to gold signal). 
 
Table 2.4 XPS elemental ratios for pNIPAM/gold hybrid nanoparticles (normalised 
to gold signal). 
 
Sample Au 4f [%] C 1s [%] O 1s [%] N 1s [%] Cu 2p [%] S 2p [%] 
Bare Au40 1.00 17.81 16.27 0.03 4.26 - 
pNIPAM100@Au40 1.00 45.41 10.72 2.29 0.82 0.012 
pNIPAM50@Au40 1.00 27.06 7.63 1.86 0.91 0.008 
pNIPAM25@Au40 1.00 20.02 5.10 1.36 0.85 0.003 
Cu foil reference - - - 59.94 40.06 - 
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These well characterised pNIPAM100@Au15 particles could now be tested for their 
responsive behaviour. As reported by Hoogenboom et al.,55 in water no transition was 
seen in the temperature range tested (25 – 85 C), but when repeated in PBS clear 
transition could be seen. These observations were attributed to the residual citrate on 
the nanoparticle surface, which was still negative charged (measured by zeta-potential) 
even after polymer coating, but approached neutrality in PBS as shown in Figure 
2.11A. The residual charge prevents aggregation due to electrostatic repulsions, but 
not in PBS due to the salt effects. Figure 2.11B shows the effect of heating the particles 
in PBS above their CP, with a clear red shift (long wavelength) in their absorption 
spectra, with an increase at 700 nm and red-blue colour shift. 
 
Figure 2.11 Solution properties of polymer coated nanoparticles. A) Zeta-potential 
analysis of nanoparticles in water, and in phosphate buffered saline; B) Example UV-
Vis spectra showing effect of heating above the transition temperature. Inset images 
show red-blue colour shift upon aggregation. 
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The thermal aggregation property of pNIPAM coated gold nanoparticles was 
confirmed by DLS measurement with increasing temperature. The hydrodynamic 
diameter for both pNIPAM100 coated 15 nm gold nanoparticles and 40 nm gold 
nanoparticles in pure water (~0.029 mg mL-1) were slightly decreased as increasing 
the temperature from 25 °C to 80 °C as shown in Figure 2.12A. The reason of reduced 
hydrodynamic diameter of pNIPAM coated gold nanoparticles is associated with the 
coil-to-globule phase transition of the immobilized polymer by dehydration as 
temperature change.  
On the contrary, when the pNIPAM coated gold nanoparticles were dispersed in PBS 
buffer with presence of salt (0.137 M of NaCl), the temperature responsive behaviour 
was exhibited in Figure 2.12B. As the temperature is increased from 25 °C to 80 °C, 
the hydrodynamic diameter for the pNIPAM coated gold nanoparticles increased. This 
is due to nanoparticle aggregation (due to hydrophobic pNIPAM above its CP) and 
hence an apparent increase in diameter and serves to highlight the importance of 
running responsive polymer/particle experiments in both pure water and saline 
solutions. The transition temperature of 55 °C for 15 nm gold nanoparticles and 60 °C 
for 40 nm gold nanoparticles were determined at significantly increasing point of 
diameter. The presence of certain level of salt in water may reduce electrostatic 
repulsion due to the charges are screened. This leads to induce the dehydrated 
pNIPAM chains to associate, and thereby interparticle aggregation is enhanced. 
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Figure 2.12 Hydrodynamic diameter for the pNIPAM coated 15 nm and 40 nm gold 
nanoparticles in A) pure water and B) PBS buffer as a function of temperature. 
 
The main aim of this study was to probe, and provide direct evidence for the co-
operative LCST transitions of polymer coated gold nanoparticles as a route to not only 
fine-tune their transition temperatures but also a way to enhance biosensing or 
generate complex assemblies of mixed particles. We have previously shown that 
pNIPAM homopolymers and various soft and hard nanoparticles show ‘co-operative 
LCST’ behaviour (scheme 2.2), but the scope and limitations of this property has not 
been fully investigated nor direct evidence for non-identical polymers or particles 
interacting.51,52,61,66,67 To probe the potential for mixing, we investigate here a range of 
different combinations of polymers and nanoparticles. 
 
Scheme 2.2 The co-operative LCST transitions of two different homopolymers mixing. 
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Firstly, pNIPAM50 and pNIPAM100 were immobilised onto Au15, using the methods 
described above. These nanoparticles solutions were then mixed with different weight 
ratio of 25 : 75, 50 : 50 and 75 : 25  respectively and their responsive transitions 
measured by UV-Vis, Figure 2.13. For the above mixtures, in each case a single 
transition temperature was observed which fell between that of the pure gold 
nanoparticles, and controlled by the mass fraction of the mixture. If independent 
transitions were occurring, two separate transitions would be expected, and the particle 
with a lower CP would not see a delay in its aggregation. This is also the first example 
of co-operative aggregation of nanoparticles with different coatings and implies that 
their responsive transitions involve interaction between the different sized 
nanoparticles rather than isolated events. 
 
Figure 2.13 Turbidimetry scans (absorbance at 700 nm) of pNIPAM50@Au15 and 
pNIPAM100@Au15 mixture of the particles with different mass fraction. The total gold 
core concentration of the solutions was 0.029 mg mL-1. 
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As a control experiment, the same pNIPAMs were first mixed in the same weight ratios 
as above (25 : 75,  50 : 50  and 75 : 25 ) and then added to the surface of gold 
particles following the same procedure as described above to give particles with 
surface heterogeneity. Whilst the homopolymer coated gold nanoparticles have sharp 
transition temperature of 55 °C and 74 °C, respectively. The CP of each particle 
conjugated with pre-mixed polymer lying between that of the two pure polymer coated 
nanoparticles are shown in Figure 2.14 and in agreement with what was seen in the 
single component nanoparticles mixtures. Taken together this shows that the transition 
of nanoparticles is highly dependent on the whole mixture and that more complex 
interactions between particles of different coatings take place. 
 
Figure 2.14 Turbidimetry scans (absorbance at 700 nm) of pre-mixture of pNIPAM50 
and pNIPAM100 with different mass fraction coated Au15 in PBS solution. The total 
gold core concentration of the solutions was 0.029 mg mL-1. 
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The above data confirms that cooperativity occurs, in that the observed transitions 
temperatures are shifted depending on the mass balance (e.g. overall MW) of the 
coating. For this hypothesis to be true, it must be that the lower CP particles 
preferentially interact (or aggregate) with the higher CP ones, or else the transition 
would not be affected; for example, if the lower CP particles interacted with each other, 
then a transition at lower temperature would be observed, followed by a step for the 
second type of particle. To enable us to probe and visualise this directly, a different co-
operative system was required which enables discrimination between particles. 
Therefore mixtures of differently sized nanoparticles were chosen, as this would give 
an observable co-operative behaviour of nanoparticles in the TEM image (vide infra). 
As shown in Figure 2.15, with the same polymer pNIPAM100 coating, transition of 15 
nm gold nanoparticles occurs at 55 °C, while 40 nm gold nanoparticles shifted the 
transition to 60 °C. The solution containing a 50 : 50 % mixture of the particles shows 
a single transition at 57 °C. 
 
Figure 2.15 Turbidimetry scans (absorbance at 700 nm) of blends with different mass 
fraction of pNIPAM100 coated Au15 and Au40. 
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This result also shows dependency of cloud point on particle size. Previous researches 
higilighted that the change in curvature at the surface of particle has dramatic 
influences on cloud points, which is not universally observed.66,68 Assuming equal 
grafting density and chain elongation, the degree of curvature decreses leading to a 
free space per polymer chain decrease, as nanoparticle size increases. Therefore, more 
crowded polymer chains decrease the cloud point of particle due to increased polymer-
polymer interactions. 
In order to explain our conflicting experimental result with the above theory, we can 
hypothesize that 15 nm gold nanoparticles actually have higher grafting density of 
pNIPAM than 40 nm gold nanoparticles, this leads to lower cloud point for small 
particle, which fits with previous research and experimental result in a similar 
manner.69,70 
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Figure 2.16 shows turbidimetry scans for blends of different particle with the different 
polymer coating. The pNIPAM100 coated 40nm gold nanoparticle had a CP of 60 °C, 
whereas the pNIPAM50 coated 15 nm gold nanoparticle had a CP of 74 °C. CPs of 
particle mixture for 25 :75 %, 50 : 50 % and 75 : 25 % with relative weight percent of 
pNIPAM50 coated 15nm gold nanoparticles and pNIPAM100 coated 40 nm gold 
nanoparticles were measured. In all cases, a single transition of particle mixture was 
observed 64 °C, 69 °C and 72 °C, showing that the CP is controlled by the relative 
weight fraction of each particles. This result proved process successfully and the CP 
of mixture particle solution is determined as a consequence of relative weight 
proportion of individual polymer coated nanoparticles. This strategy can be useful to 
control and predict CPs of polymer coated nanoparticles for desired condition. 
 
Figure 2.16 Turbidimetry scans (absorbance at 700 nm) of pNIPAM50@Au15 and 
pNIPAM100@Au40 mixture in PBS solution. The total gold core concentration of the 
solutions was 0.029 mg mL-1. 
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The above data shows the highly co-operative nature of the nanoparticle transitions, 
but to it is desirable to be able to quantify the cooperativity and provide direct evidence 
that different nanoparticles are actually interacting preferentially with their partners. 
Scheme 2.3 shows the possible outcomes which would be expected for co-operative 
and non-cooperative transitions with different size/CP particles. In the non-
cooperative case, heating above the CP of the smaller particle (lower CP) would be 
expected to only lead to aggregates of small particles forming, as the larger (Higher 
CP) particles would still be well dispersed. Conversely, if co-operative aggregation 
was occurring, then mixed aggregates containing both particles should be formed, 
explaining the modulation. 
 
 
Scheme 2.3 The possible co-operative and non-cooperative aggregates expected to 
guide TEM analysis. 
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To probe this effect a range of nanoparticle samples (both pure and mixed) were 
prepared at a range of temperatures both below the CP but also at the CP. By choosing 
at temperature at the CP the larger gold nanoparticles (with high CPs) if they are not 
interacting should not aggregate at this temperature, providing a read out for the 
cooperativity. A range of mixtures were prepared of pNIPAM100@Au15 : 
pNIPAM100@Au40 with weight ratios of  3 : 1, 1 : 1 and 1 : 3 at both 25 °C and 58 °C 
(i.e. below and at CP) and the TEM images are shown in Figure 2.17 and 2.18. 
 
 
Figure 2.17 TEM analysis of co-operative particle mixture aggregation with different 
mass fraction. Left hand column shows nanoparticles at 25 °C (below their cloud point) 
and right hand column shows the same particles which were prepared at 58 °C, above 
cloud point of the 15 nm particles, but below that of the 40 nm particles. 
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Figure 2.18 Additional TEM analysis of co-operative particle mixture aggregation 
with different mass fraction. Left hand column shows nanoparticles at 25 °C (below 
their cloud point). Right hand column shows the same particles which were prepared 
above cloud point of the 15 nm particles (58 °C) and 40 nm particles (63 °C). 
 
Figure 2.17 and 2.18 clearly revealed that in the mixed nanoparticle solutions mixed 
aggregates are forming containing both small and large particles, rather than just those 
of the lower CP material, which would be expected in a non-cooperative environment. 
In addition to be a useful method for fine-tuning transition temperatures this shows 
that the particles aggregation is clearly dependant on the other particles which they are 
in contact with and may offer opportunities particularly in biosensing where the 
aggregation of a small fraction of a sample could be enhanced by other, non-interacting 
fractions of particles. 
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2.5 Conclusions 
Here we have investigated the co-operative aggregation of a range of thermo-
responsive polymer coated gold nanoparticles. It was shown that these particles were 
tolerant to almost all possible mixing parameters to still produce a single transition; i) 
different polymers on same sized particles, ii) mixture of polymers on same sized 
particles, iii) same polymer on different sized particles and iv) different polymers on 
different sized particles in all cases enabling a route to fine-tune the transition 
temperature. Crucially, using the co-operative aggregation of differently sized 
nanoparticles it was possible to obtain direct evidence for the preferential interaction 
of large/small nanoparticles with different cloud points via the formation of mixed 
aggregations in TEM, rather than the single-sized aggregates which are found in the 
absence of cooperativity. Such observations not only provide insight in the mechanism 
of these aggregation processed but provide an opportunity to create nanomaterials 
which are capable of interacting with their environment, and also communicating this 
to other particles in the mixture, which could offer new opportunities in biosensing. 
 
2.6 Experimental Section 
2.6.1 Materials 
All chemicals were used as supplied unless otherwise stated. Methanol, hexane, 
hydrochloric acid, dichloromethane, toluene, acetone, tetrahydrofuran and diethyl 
ether were purchased from Fisher Scientific at laboratory reagent grade unless 
otherwise stated. Deuterochloroform (99.9 atom % D), 4,4'-azobis(4-cyanovaleric 
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acid) (> 97.0 %), dodecane thiol (≥ 98.0 %), potassium phosphate tribasic (reagent 
grade, ≥ 98.0 %), carbon disulfide (≥ 99.9 %), 2-bromo-2-methylpropionic acid 
(98.0 %), N-isopropylacrylamide (97.0 %), ethanolamine (≥ 99.0 %), magnesium 
sulfate (≥ 99.5 %) and mesitylene (analytical standard) were all purchased from 
Sigma-Aldrich. Ultrahigh quality water with a resistance of 18.2 M cm (at 25 °C) 
was obtained from a Millipore Milli-Q gradient machine fitted with a 0.22 m filter. 
Gold nanoparticle solutions for 15nm (0.242 mmol L-1) and 40nm (0.296 mmol L-1) 
were purchased from BBI Solutions. Pre-formulated, powdered, phosphate buffered 
saline was purchased from Sigma-Aldrich, and the desired solution made by addition 
of ultrahigh quality water to give [NaCl] = 0.137 M, [KCl] = 0.0027 M, [Na2HPO4] = 
0.01M, [KH2PO4] = 0.0018 M and pH = 7.4. 
 
2.6.2 Analytical and physical methods 
1H and 13C NMR spectra were recorded for analysis of monomer conversions and 
polymer compositions on Bruker DPX-400 spectrometer using deuterated solvents 
obtained from Sigma-Aldrich. All chemical shifts are reported in ppm () relative to 
tetramethylsilane (TMS). FTIR spectra were acquired using a Bruker Vector 22 FTIR 
spectrometer with a Golden Gate diamond attenuated total reflection cell. A total 64 
(or 128) scans with resolution of 4 cm-1 were collected. Samples were pre-dried as a 
thin film for FTIR analysis. SEC analysis was conducted on Varian 390-LC MDS 
system equipped with a column, two PL-AS RT/MT auto sampler, a PL-gel 3 mm (50 
× 7.5 mm) guard column, two PL-gel 5 mm (300 × 7.5 mm) mixed-D columns using 
dimethylformamide (DMF) with 1 mg mL-1 LiBr at 50 °C as the eluent at a flow rate 
of 1.0 mL min-1. The GPC system was equipped with ultraviolet (UV) (set at 280 nm) 
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and differential refractive index (DRI) detections. Narrow molecular weight 
poly(methyl methacrylate) (PMMA) standards (200-1.0 × 106 g mol-1) were used for 
calibration using a second order polynomial fit. Polymer solutions at 1 mg mL-1 were 
prepared in the eluent and filtered through 0.45 mm filters prior to injection. UV-vis 
spectra were recorded in a disposable cuvette using a Cary 60 UV-vis spectrometer 
from Agilent at 25 °C. Lower critical solution temperatures of free pNIPAM and 
pNIPAM nanoparticles were also analyzed using a Agilent Cary 60 UV-vis 
spectrometer equipped with a temperature controller at 700 nm with a heating/cooling 
rate of 1 °C min-1. The cloud point of pNIPAM and pNIPAM nanoparticles were 
determined by normalising the turbidimetry curve such that the values were in the 
range of 0 to 1, and the transition temperature was defined as being the temperature 
corresponding to a normalised absorbance of 0.5. A polymer concentration of 2.5 mg 
mL-1 was used in all experiments. Dynamic light scattering (DLS) and Zeta potential 
measurements were performed using a Nano-Zs from Malvern Instruments, UK 
running DTS software (4 mW, He-Ne laser,  = 633 nm) and an avalanche photodiode 
(APD) detector. The scattered light was measured at an angle of 173° for DLS 
measurement and at 12.8° for zeta potential measurements. The temperature was 
stabilized to ± 0.1 °C of the set temperature. All samples were prepared at the 
concentration of 0.029 mg mL-1 gold nanoparticles. Hydrodynamic diameter and zeta 
potential were determined using the manufacturer’s software. The size and 
morphology of the synthesized gold nanoparticles and polymer coated gold 
nanoparticles were estimated by JEOL 2000FX transmission electron microscopy 
(TEM) at an accelerating voltage 200 kV. A drop of sample solution was deposited 
onto a copper grid and the water was evaporated under air. No staining was applied. 
The x-ray photoemission spectroscopy (XPS) data were collected at the Warwick 
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Photoemission Facility, University of Warwick, more details of which are available at 
reference.71 The samples investigated in this study were deposited on to Cu foil, 
mounted on to a sample bar and loaded in to a Kratos Axis Ultra DLD spectrometer 
which possesses a base pressure of ~ 5 × 10-10 mbar. XPS measurements were 
performed in the main analysis chamber, with the sample being illuminated using an 
Al kα x-ray source. The measurements were conducted at room temperature and at a 
take-off angle of 90° with respect to the surface parallel. The core level spectra were 
recorded using a pass energy of 20 eV (resolution approx. 0.4 eV). The spectrometer 
work function and binding energy scale were calibrated using the Fermi edge and 3d5/2 
peak recorded from a polycrystalline Ag sample immediately prior to the 
commencement of the experiments. The data were analysed in the CasaXPS package, 
using Shirley backgrounds, mixed Gaussian-Lorentzian (Voigt) lineshapes. For 
compositional analysis, the analyser transmission function has been determined using 
Ag, Au and Cu foils to determine the detection efficiency across the full binding 
energy range. 
 
2.6.3 Synthetic procedures 
Synthesis of 2-(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (DMP) 
Dodecane thiol (4.00 g, 4.73 mL, 19.76 mmol) was added dropwise to a stirred 
suspension of K3PO4 (4.20 g, 19.76 mmol) in acetone (60 mL) over 25 minutes. CS2 
(4.10 g, 3.24 mL, 53.85 mmol) was added and the solution turned bright yellow. After 
stirring for ten minutes 2-bromo-2-methylpropionic acid (3.00 g, 17.96 mmol) was 
added and a precipitation of KBr was noted. After stirring for 16 hour, the solvent was 
removed under reduced pressure and the residue was extracted into CH2Cl2 (2 × 200 
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mL) from 1M HCl (200 mL). The organic extracts were washed with water (200 mL) 
and brine (200 mL) and further dried over MgSO4. The solvent was removed under 
reduced pressure and the residue was purified by recrystallization in hexane. 
1H NMR (400 MHz, CDCl3) ppm: 3.28 (2H, t, J12-11= 7.54 Hz, H12); 1.71 (6H, s, H13); 
1.67 (2H, p, J11-10, 11-12 = 7.53 Hz, H
11); 1.38 (2H, p, J10-9, 10-11= 7.78 Hz, H
10); 1.26 
(16H, m, H2-9); 0.88 (3H, t, J1-2= 7.03 Hz, H
1). 
13C NMR (400 MHz, CDCl3) ppm: 196.00 (C13); 177.56 (C16); 64.69 (C14); 37.09 
(C12); 31.92, 29.71, 29.63, 29.56, 29.45, 29.35, 29.12, 22.70 (C2-9); 28.97 (C10); 27.81 
(C11); 25.25 (C15); 14.13 (C1). 
IR cm-1: 2916 (alkyl-H stretch); 1710 (C=O stretch); 1068 (S-(C=S)-S stretch). 
HRMS (ESI +) m/z: 365.1632 [M+H]+; expected 365.1637 (C17H33O2S3). 
 
Polymerization of N-isopropylacrylamide using 2-
(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (DMP)  
Polymers with three different molecular weights were synthesised in typical 
procedure.72 N-isopropylacrylamide (1 g, 8.84 mmol), 2-
(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (32.22 mg, 88.4 mol), and 
4,4'-azobis(4-cyanovaleric acid) (ACVA) (4.95 mg, 17.7 mol) were dissolved in 
methanol/toluene (1 : 1; 4mL) in a glass vial containing a stir bar giving [monomer] : 
[chain transfer agent] : [initiator] = 100 : 1 : 0.2. Mesitylene (150 L) was added as an 
internal reference and the mixture was stirred (5 mins). An aliquot of this starting 
mixture was removed for 1H NMR analysis. The vial was fitted with a rubber septum 
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and degassed by bubbling with nitrogen gas (30 mins). The vial was then placed in an 
oil bath thermostated at 70 °C. After 35 minutes, the reaction mixture was opened to 
air and quenched in liquid nitrogen. An aliquot was removed and conversion 
determined by 1H NMR. The remainder was precipitated into diethyl ether (45 mL). 
The polymer was re-precipitated and purified from THF to diethyl ether three times. 
The product was purified three times by precipitation from toluene into diethyl ether, 
isolated centrifugation, and dried under vacuum overnight to give a yellow solid. The 
overall monomer conversion was determined from the 1H NMR spectrum by 
measuring the decrease in intensity of the vinyl peaks associated with the monomer 
relative to mesitylene. Conversion (NMR): 72 %; Mn (theoretical), 8100 g mol
-1; Mn 
(SEC), 7700 g mol-1; Mw/Mn (SEC), 1.10. 
 
General procedure for the synthesis of polymer-coated gold nanoparticles 
Approximately 1 mg of the pNIPAM was added to a microcentrifuge tube, and 
dissolved in 100 L of high-purity water. For the desired thiol-terminated polymer, 
ethanolamine (50 mol equiv of pNIPAM) was also added. To this tube 900 L of the 
citrated-stabilized gold nanoparticle solution was added (15 nm: 0.242 mmol L-1, 40 
nm: 0.296 mmol L-1 total gold concentration), which was then agitated overnight in 
the absence of light. To remove excess polymer, the particles were centrifuged for 30 
minutes at 10000 rpm. Following careful decantation of the supernatant, the particles 
were then re-dispersed in 1 mL of high-quality water and the centrifugation-
resuspension process repeated for a total of 3 cycles. After the final cycle the particles 
were dispersed in 1 mL of high-quality water for future use. Assuming complete 
incorporation of the citrate coated gold particles into the final polymer coated particles 
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the total gold concentration in the final solution was 0.242 mmol L-1, 0.048 mg mL-1 
and 0.296 mmol L-1, 0.058 mg mL-1. 
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Chapter 3 
3. Externally Controllable Glycan 
Presentation on Nanoparticle Surfaces to 
Modulate Lectin Recognition 
 
3.1 Chapter summary 
In this chapter, polymer tethered gold nanoparticles as a temperature-controlled 
colourimetric detector of target lectins based on the molecular recognition of galactose 
modified pHEA and the thermo-sensitivity based on the coil-to-globule phase 
transition of pNIPAM as a blocking agent will be reported. 
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3.2 Abstract 
Nature dynamically controls carbohydrate expression on cells rather than static 
presentation. Here we report synthetic glycosylated nanoparticles that contain 
polymeric ‘gates’ to enable external control (via temperature changes) of glycan 
surface expression, as an alternative to enzymatic control in Nature. This approach 
offers a new dynamic multivalent scaffold for glycan recognition. 
 
3.3 Introduction 
Glycans (sugars) mediate a diverse range of biological recognition and signal 
transduction pathways and are implicated in diseases such as cancer (aberrant 
glycosylation) or as sites for pathogen adhesion. The ‘readers’ of glycosylation state 
are lectins; carbohydrate binding proteins which are neither antibodies nor enzymes.1 
The typical affinity for a glycan to a lectin is rather weak (Kd: ~ mM), so Nature 
presents multiple copies of glycans on cell surfaces to benefit from the cluster 
glycoside effect – a non-linear enhancement in binding affinity when multiple glycans 
are present in proximity to each other (Kd: ~ nM).
2 Inspired by this, multivalent 
systems such as polymers, peptides, surfaces or nanoparticles functionalised with 
glycans have been used to generate high avidity binders. Due to their high affinity, 
glycopolymers3,4 have been explored as anti-adhesive agents against, HIV,5 cholera,6 
Shiga toxins7 and also to recruit growth factors to control stem cell fate8 with affinities 
on the nM scale. 
Despite this vast range of structures synthesized, most glycomaterials are static entities 
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with the sugars always accessible for binding. This is in stark contrast to cell-surface 
glycans which are highly dynamic with the glycans presented changing depending on 
disease state and for protein folding quality control.9,10 Current synthetic materials do 
not enable control over glycan expression to be modulated, and hence do not fully 
mimic the natural environment. Dynamic chemical bonds have been used to generate 
glycopolymers which reconfigure due to the action of lectin binding (i.e. internal 
trigger), but not to an external trigger.11,12,13 In contrast, externally addressable 
polymers (often termed as ‘smart’ or ‘responsive’) have been extensively studied 
where an external stimulus, such as light, heat, pH, radiation, metal ions etc., can 
trigger a (reversible) change in material properties. In particular, thermo-responsive 
polymers have attracted attention as due to their easy synthesis and diverse range of 
applications from triggered cellular uptake, trypsin-free cell release14 and drug 
delivery.15 Polymers which display an LCST (lower critical solution temperature) 
undergo a chain collapse (soluble – insoluble) upon heating providing a macroscopic 
effect from the external trigger.16,17 Typical thermo-responsive polymers with an 
LCST include poly(N-isopropylacrylamide) (pNIPAM) and poly[(oligoethylene 
glycol) methacrylates] (pOEGMAs) due to their transitions being close to 37 C. Many 
other classes have been developed and extensively reviewed.18,19 Immobilization of 
responsive polymers onto metal or soft nanoparticle enables dynamic control over 
aggregation state based on an external trigger.20,21 Mastrotto et al. used pNIPAM 
collapse to expose folate moieties on gold nanoparticle surfaces to enable temperature 
triggered uptake into cancerous cell lines.22 Temperature gating has also been used to 
control access to biotin functionality on glass surfaces.23 Gold nanoparticles (AuNPs) 
are widely used due to their easy functionalization with thiols and unique optical 
properties which make them excellent contrast agents in electron microscopy, or dark 
111 
 
field microscopy, but also as colourimetric sensors due to the coupling of their SPR 
bands when aggregated leading to a red-blue colour shift.24 Immobilization of glycans 
onto AuNPs has been used as biosensors. Field et al, used α2,6-thio-linked sialic acid 
to detect human influenza,25 and Richards et al. have used glycosylated gold 
nanoparticles libraries as multiplex sensors.26  
Considering the above, we reasoned that if a nanoparticle surface could be formulated 
correctly, a responsive polymer could be used as an externally addressable ‘gate’ 
which upon application of a stimulus, is ‘opened’ (via chain collapse) to enable access 
to a glycan and hence enable binding. This can be considered as a synthetic alternative 
to enzyme expression levels, which in vivo control glycan expression based upon 
biological triggers. 
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3.4 Result and Discussion 
To provide the desired gating mechanism on the nanoparticle surface pNIPAM was 
selected as the thermo-responsive polymer due to its well characterised switchable 
behaviour and high grafting density onto gold.27 Well-defined poly(hydroxyethyl 
acrylamide) (pHEA) was selected as a non-responsive co-coating as we have 
previously demonstrated it to be an excellent stabilizing polymer for glyco-
nanoparticles.28 RAFT (reversible addition fragmentation chain transfer) 
polymerization29 was employed as it enables control over molecular weight and also 
installs sulfur containing end-groups. Finally, nucleophiles treated pNIPAM and 
glycan modified pHEA (glycans act as nucleophiles through post-polymerization 
modification process) were achieved as an outcome of trithiocarbonate end-group 
removal and these thiol functionalised polymers allow direct conjugation onto 
AuNPs29 as shown in Scheme 3.1. 
 
Scheme 3.1 Synthesis of polymers by RAFT polymerization and polymer conjugation 
onto AuNPs. 
AuNPs
n
n
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pHEA was synthesized using a pentafluorophenyl (PFP) ester RAFT agent, which 
enabled quantitative installation of 2-deoxy, 2-amino galactose post-polymerization, 
confirmed by 19F NMR (Figure 3.1) and FT-IR. Infrared analysis of pHEA was 
conducted before and after reaction of pentafluorophenol end-group with 
galactosamine. Disappearance of C=O at around 1750 cm-1 attributable to the carbonyl 
associated with the PFP end-group being removed as shown in Figure 3.2. 
 
Figure 3.1 19F NMR spectra of PFP-pHEA15. 
 
Figure 3.2 Infrared spectra of PFP-pHEA (red) and galactosamine-pHEA (blue). 
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Well-defined pHEA with DP = 15 was synthesised, along with two different pNIPAMs 
with DP 25 or 50, confirmed by size exclusion chromatography (SEC) and NMR, as 
shown in Table 3.1 and Figure 3.3. Molecular weight of all polymers determined by 
SEC are slightly higher than the theoretical values (were in decent agreement with the 
theoretical values), indicating well-defined polymerization with narrow poly 
dispersity below 1.1. As expected, the pNIPAMs displayed a lower critical solution 
temperature in solution (Table 3.1) of approximately 36 C, which is essential for the 
gating concept, (below). All polymers were purified by dialysis against water prior to 
use. 
Table 3.1 Polymer used in this study. 
Polymer [M]/[CTA]/[I] 
[mol] 
Mn Target 
[gmol-1] 
Conversiona) 
[%] 
Mn Theob) 
[gmol-1] 
Mn SECc) 
[gmol-1] 
Mw/Mn 
[-] 
Cloud Pointd) 
[C] 
pNIPAM25 25/1/0.2 3200 87 % 2800 2900 1.07 36 
pNIPAM50 50/1/0.2 6000 86 % 5200 7100 1.10 38 
PFP-pHEA15 15/1/0.2 2300 93 % 2100 4800 1.10 - 
pNIPAMxxx / pHEAxxx = poly(N-isopropylacrylamide) / poly(hydroxyethyl 
acrylamide) where average degree of polymerization indicated by xxx; a)Determined 
1H NMR; b)Calculated from the [monomer]:[CTA] ratio and of conversion; 
c)Determined by SEC in DMF using PMMA standards; d)Cloud point was measured in 
water upon heating from 25 C to 80 C, 1.0 mg mL-1 polymer concentration. 
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Figure 3.3 SEC analysis of polymer. 
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The gating concept, whereby increasing the temperature leads to selective collapse of 
the pNIPAM chains and consequently exposing the glycan is shown in Scheme 3.2. 
The polymer coatings had to fulfil several criteria for this concept to be successful i) 
long enough to promote colloidal stability; ii) correct ratio of responsive and glycan 
bearing polymer to ensure multivalent enhancement, but retain colloidal stability after 
pNIPAM collapse; iii) provide enough steric bulk to block glycan access below 
collapse temperature. 
 
Scheme 3.2 Concept of using responsive polymers to gate access to nanoparticles. 
Below the LCST of pNIPAM steric hindrance prevents lectin binding to glycans, but 
above the LCST, the polymer collapse to expose glycans enabling binding and 
aggregation of the particles. 
 
The thiol-terminated pHEA15-Gal (galactose functional pHEA) and pNIPAM with 
different molar ratio was attached onto pre-formed gold nanoparticles directly by a 
simple mixing procedure and excess polymer removed by centrifugation-resuspension 
dialysis. The increase in diameter and red-shifted spectrum of wavelength measured 
by both DLS and UV-Vis spectrum indicating that gold nanoparticles (in 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N′-
(2-ethanesulfonic acid) (HEPES) buffered solution) successfully functionalised by 
each polymer as shown in Table 3.2. 
T > CP
Target Lectin
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Table 3.2 Gold nanoparticles with pHEA-Gal and pNIPAM functionalisation. 
Particle SPR particle 
[nm]a) 
Diameter 
[nm]b) 
Cloud point HEPES 
[°C]c) 
Bare gold 40 nm 527 42 - 
pHEA15-Gal@Au40 530 50 - 
Bare gold 60 nm 534 58 - 
pHEA15-Gal@Au60 537 66 - 
pNIPAM25@Au60 537 64 64 
pHEA15-Gal(2)/pNIPAM25(8)@Au60 537 64 67 
pHEA15-Gal(5)/pNIPAM25(5)@Au60 537 66 72 
pHEA15-Gal(8)/pNIPAM25(2)@Au60 538 66 78 
pNIPAM50@Au60 538 75 61 
pHEA15-Gal(8)/pNIPAM50(2)@Au60 538 68 50 
pHEA15-Gal(9)/pNIPAM50(1)@Au60 538 67 52 
a)SPR maximum of gold nanoparticles after coating with polymer; b)Z-average 
diameter determined by DLS; c)Cloud point was measured in HEPES buffer upon 
heating from 25 °C to 80 °C, 0.057 mg mL-1 total particle concentration. The CP (cloud 
point) of particles defined as being the point of 50% transmittance by UV-Vis 
spectroscopy. 
 
In addition, CPs of each particle was determined by turbidimetry curves using UV-vis. 
We observed each pNIPAM coated gold nanoparticle has over 60 °C of CPs, whereas 
glycopolymer coated nanoparticle has no CP due to its none-thermal responsivity (see 
Figure 3.4). From particles characterisation, our polymer coated particles are stable at 
saline condition in HEPES buffer confirmed by no aggregates of particles and no 
changes of UV-vis absorbance peaks even after long period of incubation (data not 
shown).  
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Also, particles are perfectly matched to this work because if gold particles are 
decorated with both thermo-responsive pNIPAM and non-thermal responsive 
pHEA15-Gal, then CP of particles would be increased above only pNIPAM coated gold 
particles CPs (higher than 60 °C). But unlike our expectation, both pHEA15-Gal and 
pNIPAM50 (9:1 molar ratio) coated 60 nm sized gold nanoparticle has a lower CP of 
52 °C, compared to the pNIPAM coated particles. However, the CP is the temperature 
where the particles aggregate, and the actual collapse of the pNIPAM will occur below 
this. The data (below) shows that the desired switching behaviour between 20 and 40 
oC can occur, even though the observed pHEA15-Gal(9)/pNIPAM50 particle’s CP 
(52 °C). This is a crucial component of our system, to ensure there are no false 
positives due to temperature induced particle aggregation, rather than the desired 
glycan-induced assembly. 
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Figure 3.4 Turbidimetry scans (absorbance at 700 nm) of pure pNIPAMs (1.0 mg mL-
1) and polymer functionalised gold nanoparticles (0.057 mg mL-1). 
 
At the very first stage, 40 and 60 nm sized gold nanoparticles were functionalised with 
only pHEA15-Gal to confirm the gold core size dependency for protein binding 
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efficiency. These particles were evaluated for binding with Soybean agglutinin (SBA) 
which has a preference for GalNAc binding and as it has 2 binding sites,30 can hence 
lead to aggregation of glycosylated gold nanoparticles (glycoAuNPs). The binding 
interaction result in crosslink (aggregation) of particles and can be confirmed by 
analysis of the red to blue solution colour change and UV-spectra shifts due to coupling 
of the particle SPR bands, as shown in Figure 3.5. Both 40 and 60 nm particles were 
rapidly aggregated and changed solution colour from red to blue upon addition of 
highest concentration of SBA (10-2 mg mL-1). This leads to significant change of the 
SPR peak to broader peak and longer wavelength in UV-vis spectrum. However, core 
60 nm gold nanoparticles clearly showed dose-dependent response to the serial SBA 
dilution through increasing in absorbance at 700 nm than 40 nm core gold 
nanoparticles (see Figure 3.5B). This initial screens using pHEA15-Gal coated 
nanoparticles in lectin aggregation assays indicated that 60 nm nanoparticles gave 
larger and faster responses than 40 nm particles due to theoretically higher grafting 
density for larger particle and hence is the diameter used from this point onwards.28 
 
Figure 3.5 UV-vis spectrum and photographs of colour changes of pHEA15-Gal coated 
A) 40 nm and B) 60 nm sized gold nanoparticles upon addition of serial dilution of 
SBA (0 – 10 g mL-1) following 30 mins of incubation at 20 °C. 
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To investigate the morphology of particle aggregation, TEM analysis was conducted. 
TEM images of Figure 3.6A and 3.6C clearly prove that pHEA15-Gal coated gold 
nanoparticles have high colloidal stability at both 20 °C and 40 °C without addition of 
SBA and hence that any pNIPAM collapsed does not lead to aggregation for these 
mixed nanoparticles. Figure 3.6B shows the morphology of particle aggregates due to 
SBA particle binding at 20 °C. Also, the function (glycan binding) of SBA was not 
affected by the increased temperature to 40 °C as shown in particle aggregates of 
Figure 3.6D . 
 
Figure 3.6 TEM images of pHEA15-Gal coated 60 nm gold nanoparticles A), C) non-
aggregation without SBA B), D) aggregation with SBA (10 g mL-1) following 30 
minutes of incubation at 20 °C and 40 °C, respectively. 
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X-ray photoelectron spectroscopy (XPS) was used to provide additional chemical 
characterisation of the grafting-to success, as shown in Table 3.3 and Figure 3.7. The 
appearance of nitrogen and sulphur peaks which are not present in the citrate-stabilised 
precursor particles demonstrates addition of the polymers. No significant differences 
in density were seen between the polymers used on their own, suggesting that the feed 
ratio will be close to the obtained ratio on the particle surface. It is important to note 
that we cannot obtain exact polymer grafting densities for the particle from the XPS 
analysis in this study. Assuming 0.3 chains nm-2 from thermogravimetric analysis 
(TGA) in the previous work in a similar manner to producing thermo-responsive 
particle,31 this gives ~ 3000 chains of polymer (0.3 × 4r2) per gold nanoparticle. 
 
Table 3.3 XPS elemental ratios for polymer/gold hybrid nanoparticles (normalised 
to gold signal). 
 
Sample Au 4f 
[%] 
C 1s 
[%] 
O 1s 
[%] 
N 1s 
[%] 
S 2p 
[%] 
pHEA15-Gal (9) / pNIPAM50 (1) @Au60 0.35 57.76 34.92 6.18 0.79 
pHEA15-Gal (9) @Au60 0.52 60.54 34.37 3.75 0.81 
pNIPAM50 (1) @Au60 1.48 64.37 27.87 5.77 0.50 
 
Sample Au 4f 
[%] 
C 1s 
[%] 
O 1s 
[%] 
N 1s 
[%] 
S 2p 
[%] 
pHEA15-Gal (9) / pNIPAM50 (1) @Au60 1.00 165.03 99.77 17.66 2.26 
pHEA15-Gal (9) @Au60 1.00 116.42 66.10 7.21 1.56 
pNIPAM50 (1) @Au60 1.00 43.49 18.83 3.90 0.34 
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Figure 3.7 X-ray photoelectron spectroscopy analysis of polymer functionalised gold 
nanoparticles. Representative high-resolution XPS spectrum of C1s, N1s and O1s 
region after pHEA15-Gal (9)-pNIPAM50 (1); pHEA15-Gal; pNIPAM50 conjugation. A) 
Carbon (C1s) peak, B) nitrogen (N1s) peak and C) Oxygen (O1s) peak from the XPS 
analysis of polymer/gold hybrid nanoparticles (normalised to gold signal). 
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In a first series of experiments pHEA15-Gal was mixed with pNIPAM25 in three 
different molar ratios of 8:2, 5:5 and 2:8 used to functionalise 60 nm AuNPs. Particle 
responses were measured by UV-vis after 30 mins incubation at 20 °C and 40 °C (i.e. 
above and below the collapse temperature of pNIPAM) in the presence of SBA. 
Spectra are shown for 2:8 and 5:5 molar ratio of pHEA15-Gal and pNIPAM25 particles 
at both different temperature (see Figure 3.8). From this result, the fraction of pHEA-
Gal is too small, relative to pNIPAM to enable SBA-induced aggregation and that the 
gating concept requires precision tuning of the glycan/blocking polymer ratio. 
 
Figure 3.8 UV-Vis traces of different nanoparticle formulations in presence of serial 
dilution of SBA (0 – 0.01 mg mL-1) after 30 minutes incubation. Gold particles (60 
nm) had [pHEA15-Gal]:[pNIPAM25] 2:8 at 20 C A) and 40 C B); [pHEA15-
Gal]:[pNIPAM25] 5:5 at 20 C C) and 40 C D). An increase in Abs700 and decrease in 
Abs540 is indicative of binding. All curves normalise so Abs450 = 1. Arrow indicates 
increase concentration. 
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With 8:2 molar ratio of pHEA15-Gal and pNIPAM25 coating, addition of SBA at either 
20 or 40 C leads to a clear change in colour from red to blue, with a shift in the Absmax 
to longer wavelengths. This indicated that the pNIPAM25 provided an insufficient 
steric block due to short polymer chain length and that the Gal-residues were 
accessible at both temperatures as shown in Figure 3.9A and B. This shows that as 
well as density, the relative chain lengths of the polymers are crucial to get the dynamic 
surface coatings. 
Switching to the pNIPAM50 (8:2 molar ratio of pHEA15-Gal:pNIPAM50) coating, and 
again exposing to SBA showed no interaction with SBA after 30 minutes incubation 
at 20 C showing that this polymer was sufficiently bulky to limit access to the Gal 
residues (Figure 3.9C). Upon increasing the temperature to 40 C, in the presence of 
SBA, there was a small, but significant shift in the UV-Vis spectra of Figure 3.9D with 
an increase at 700 nm and decrease at 540 nm indicative of lectin binding and 
aggregation. This clearly demonstrated that the concept of responsive gating to glycan 
access could be achieved, but that the surface coating has to be precisely tuned to 
achieve the balance required. Further optimisation studies revealed that changing the 
ratio of pHEA15-Gal : pNIPAM50 from 8:2 to 9:1 provided the optimum balance 
between glycan affinity (i.e. aggregation) and switchability. 
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Figure 3.9 UV-Vis traces of different nanoparticle formulations in presence of serial 
dilution of SBA (10 – 1 g mL-1) after 30 minutes incubation. All particles (60 nm) 
had [pHEA15-Gal]:[pNIPAMx] 8:2. pNIPAM25 at 20 C A) and 40 C B); pNIPAM50 
at 20 C C) and 40 C D). An increase in Abs700 and decrease in Abs540 is indicative 
of binding. All curves normalise so Abs450 = 1. Arrow indicates increase concentration. 
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To ensure the changes seen were due to particle aggregation (indicative of lectin-cross-
linking), SBA binding was investigated using dynamic light scattering and 
transmission electron microscopy (TEM) Figure 3.10. The optimised nanoparticle 
formulation (above) was incubated with SBA at both 20 and 40 C for 30 minutes and 
the observed hydrodynamic diameters shown in Figure 3.10A and B. At 20 C, in the 
presence of various concentrations of SBA, there was no change in hydrodynamic 
diameter from the initial 60 nm. At 40 C, with no SBA added, the particles were stable 
with the initial diameter of ~ 80 nm (due to some surface reconfiguration compared to 
at 40 C) being retained, in agreement with the UV-Vis data. Following 30 minutes of 
incubation there was a clear dose-dependent increase in the aggregate size as [SBA] 
was increased, again supporting the hypothesis that the pNIPAM is gating access to 
the glycan. TEM analysis was also conducted to provide direct evidence of 
temperature triggered lectin/particle agglutination. Figure 3.10C shows nanoparticles 
plus SBA at 20 C, which are clearly well-dispersed and Figure 3.10D shows the 
aggregates which form upon heating to 40 C only in the presence of SBA. 
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Figure 3.10 Dynamic light scattering (DLS) analysis of thermally gated lectin binding. 
pHEA15-Gal:pNIPAM50 ratio 9:1 @AuNP60. A) Hydrodynamic diameter at 20 C 
initially, and after 30 minutes incubation with SBA; B) Hydrodynamic diameter at 40 
C, initially and after 30 minutes incubation with SBA. All results are mean from a 
minimum of 3 independent repeats. TEM images of these particles after addition of 
SBA (10 g mL-1): C) at 20 C for 30 mins; D) at 40 C following 30 minutes 
incubation. 
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As a final test of the system, the optimised nanoparticle formulation (with the 9:1 ratio 
of pHEA15-Gal:pNIPAM50) was interrogated with a panel of lectins, with different 
binding specificities32 at both 20 C and 40 C. SBA, Wheat germ agglutinin (WGA), 
Ulex europaeus agglutinin (UEA) and Ricinus communis agglutinin 120 (RCA120) 
were employed. At 20 C there was no measurable change in UV-Vis spectra of Figure 
3.11 upon incubation with SBA, WGA, UEA or RCA120 lectins, indicating that the 
glycan is sterically shielded against all the lectins. 
 
 
Figure 3.11 Assessment of specificity of thermally gated nanoparticles to a panel of 
lectins. Lectin concentration is 1 – 10 g mL-1. A – D) show UV-Visible traces 
(normalised to Abs450) following 30 minutes incubation at 20 C with indicated lectin. 
Arrow indicates increase concentration. 
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Increasing the temperature to 40 C, however, lead to clear changes in the UV-Vis 
spectra for SBA, RCA120 and WGA as would be expected with their known affinities 
for Gal (or GalNAc/GluNAc for WGA) as shown in Figure 3.12. The control lectin 
UEA, which has specificity for fucose residues did not bind at any temperature, 
proving the specificity of the interaction and that temperature-induced aggregation is 
not a factor. A partial isotherm showing the relative changes is included in the 
supporting information as a measure of the relative affinity, in the order 
SBA>WGA~RCA120>>>UEA. 
 
 
Figure 3.12 Assessment of specificity of thermally gated nanoparticles to a panel of 
lectins. Lectin concentration is 1 – 10 g mL-1. A – D) show UV-Visible traces 
(normalised to Abs450) following 30 minutes incubation at 40 C with indicated lectin. 
Arrow indicates increase concentration. 
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To test the specificity of the glyco-particle interactions, and rule out non-specific 
protein binding, control experiments were conducted using Bovine serum albumin 
(BSA) as a non-carbohydrate binding protein (Figure 3.13). Non responsive, 
galactosylated pHEA coated particles were incubated with a serial dilution of BSA and 
the UV-Vis spectra recorded, showing no change. Accordingly, the same experiment 
was undertaken with the pNIPAM containing particles at both low and high 
temperature (i.e. where we see activation towards lectin binding). No change was seen 
indicating there was no aggregation induced by non-specific effects. The ability to 
control glycan expression would be a powerful tool for studying the role of 
multivalency intracellularly, where the glycan is only exposed when trafficked to the 
desired location, potentially provided spatiotemporal control. They could also be used 
as new biomolecular logic gates. 
 
Figure 3.13 Control experiments for non-specific interactions with non-carbohydrate 
binding protein, BSA. A) pHEA15-Gal@Au60 at 20 C; B) pHEA15-Gal (9)-
pNIPAM50(1) @Au60 at 20 C; C) pHEA15-Gal (9)-pNIPAM50(1) @Au60 at 40 C. 
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3.5 Conclusions 
In summary, we have demonstrated a new concept in glyco-engineering where 
responsive polymer surfaces, rather than external enzyme expression levels, control 
the display of sugars on the surface of a nanoparticle, which could be considered a 
simple cell mimetic. The ‘gate’ pNIPAM had to be added in a relatively low ratio 
compared to the glycan-bearing polymer to ensure a binary on/off effect, with 
significant lectin binding above the pNIPAM LCST observed. The specificity of the 
GlycoAuNP was confirmed against a panel of lectins, with glycan expression only 
being induced above the critical temperature. The complex function of this relatively 
simple system with in-built optical outputs (AuNP colour changes) is highly versatile 
and presents a new method to dynamically control glycan expression using fully 
synthetic systems. By controlling presentation on the AuNP surface with an external 
trigger, we can envisage this being used as a tool to probe glycan function under very 
controlled environments, including intracellularly and could be considered a 
molecular ‘AND’ gate. Furthermore, the pNIPAM collapse could be replaced with a 
range of other stimuli responsive polymers, to enable biochemical rather than 
temperature trigger to probe more complex cellular environments. 
 
3.6 Experimental Section 
3.6.1 Materials 
All chemicals were used as supplied unless otherwise stated. Methanol, hexane, 
hydrochloric acid, dichloromethane, toluene, acetone, tetrahydrofuran and diethyl 
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ether were purchased from Fisher Scientific at laboratory reagent grade. 
Deuterochloroform (99.9 atom % D), Deuteromethanol (99.5 atom % D), 4,4'-
azobis(4-cyanovaleric acid) (> 97.0 %), dodecane thiol (≥ 98.0 %), potassium 
phosphate tribasic (reagent grade, ≥ 98.0 %), carbon disulfide (≥ 99.9 %), 2-bromo-2-
methylpropionic acid (98.0 %), N-isopropylacrylamide (97.0 %), 
hydroxyethylacrylamide (97.0 %), N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide 
hydrochloride (98.0 %), ethanolamine (≥ 99.0 %), magnesium sulfate (≥ 99.5 %) and 
mesitylene (analytical standard) were all purchased from Sigma-Aldrich. 4-
(Dimethylamino)pyridine (99.0 %), pentafluorophenol (99.0 %) and trimethylamine 
(99.0 %) were purchased from Acros. Clear, polystyrene, flat-bottom, half-area 96-
well microtiter plates were purchased from Greiner Bio-one. 10 mmol 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N′-
(2-ethanesulfonic acid) (HEPES) buffer containing 0.15 M NaCl, 0.1 mM CaCl2 and 
0.01 mM MnCl2 (pH 7.5, HEPES) was prepared in 200 mL of milliQ water (with a 
resistance of 18.2 M cm). Gold nanoparticle solutions for 40 nm (0.296 mmol L-1) 
and 60nm (0.288 mmol L-1) were purchased from BBI Solutions. Soybean Agglutinin, 
Ricinus Communis Agglutinin, Ulex Europaeus Agglutinin, Wheat Germ Agglutinin 
and Bovine serum albumin were purchased from Vector Labs. D-Galactosamine 
Hydrochloride was purchased from Carbosynth Ltd. 
 
3.6.2 Analytical and physical methods 
1H, 13C and 19F NMR spectra were recorded for analysis of monomer conversions and 
polymer compositions on Bruker HD-300 and HD-500 spectrometer using deuterated 
solvents obtained from Sigma-Aldrich. All chemical shifts are reported in ppm () 
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relative to tetramethylsilane (TMS). FTIR spectra were acquired using a Bruker Vector 
22 FTIR spectrometer with a Golden Gate diamond attenuated total reflection cell. A 
total 64 (or 128) scans with resolution of 4 cm-1 were collected. Samples were pre-
dried as a thin film for FTIR analysis. SEC analysis was conducted on Varian 390-LC 
MDS system equipped with a column, two PL-AS RT/MT auto sampler, a PL-gel 3 
mm (50 × 7.5 mm) guard column, two PL-gel 5 mm (300 × 7.5 mm) mixed-D columns 
using dimethylformamide (DMF) with 1 mg mL-1 LiBr at 50 °C as the eluent at a flow 
rate of 1.0 mL min-1. The GPC system was equipped with ultraviolet (UV) (set at 280 
nm) and differential refractive index (DRI) detections. Narrow molecular weight 
poly(methyl methacrylate) (PMMA) standards (200-1.0 × 106 g mol-1) were used for 
calibration using a second order polynomial fit. Polymer solutions at 1 mg mL-1 were 
prepared in the eluent and filtered through 0.45 mm filters prior to injection. UV-vis 
spectra were recorded in a disposable cuvette using a Cary 60 UV-vis spectrometer 
from Agilent at 25 °C. Lower critical solution temperatures of free pNIPAM and 
pNIPAM nanoparticles were also analyzed using an Agilent Cary 60 UV-vis 
spectrometer equipped with a temperature controller at 700 nm with a heating/cooling 
rate of 1 °C min-1. The cloud point of pNIPAM and pNIPAM nanoparticles were 
determined by normalising the turbidimetry curve such that the values were in the 
range of 0 to 1, and the transition temperature was defined as being the temperature 
corresponding to a normalised absorbance of 0.5. A polymer concentration of 1.0 mg 
mL-1 was used in all experiments. DLS measurements were performed using a Nano-
Zs from Malvern Instruments, UK running DTS software (4 mW, He-Ne laser,  = 
633 nm) and an avalanche photodiode (APD) detector. The scattered light was 
measured at an angle of 173° for DLS measurement. The temperature was stabilized 
to ± 0.1 °C of the set temperature. All samples were prepared at the concentration of 
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0.057 mg mL-1 gold nanoparticles. Hydrodynamic diameter were determined using the 
manufacturer’s software. Absorbance measurements of the nanoparticles incubated 
with lectin were recorded on a BioTek SynergyTM HT multi-detection microplate 
reader obtained using Gen5 1.11 multiple data collection and analysis software. The 
size and morphology of the synthesized gold nanoparticles and polymer coated gold 
nanoparticles were estimated by JEOL 2100FX transmission electron microscopy 
(TEM) at an accelerating voltage 200 kV. A drop of sample solution was deposited 
onto a copper grid and the water was evaporated under air. No staining was applied. 
The x-ray photoemission spectroscopy (XPS) data were collected at the Warwick 
Photoemission Facility, University of Warwick, more details of which are available at 
reference.33 The samples investigated in this study were deposited on to Cu foil, 
mounted on to a sample bar and loaded in to a Kratos Axis Ultra DLD spectrometer 
which possesses a base pressure of ~ 5 × 10-10 mbar. XPS measurements were 
performed in the main analysis chamber, with the sample being illuminated using an 
Al kα x-ray source. The measurements were conducted at room temperature and at a 
take-off angle of 90° with respect to the surface parallel. The core level spectra were 
recorded using a pass energy of 20 eV (resolution approx. 0.4 eV). The spectrometer 
work function and binding energy scale were calibrated using the Fermi edge and 3d5/2 
peak recorded from a polycrystalline Ag sample immediately prior to the 
commencement of the experiments. The data were analysed in the CasaXPS package, 
using Shirley backgrounds, mixed Gaussian-Lorentzian (Voigt) lineshapes. For 
compositional analysis, the analyser transmission function has been determined using 
Ag, Au and Cu foils to determine the detection efficiency across the full binding 
energy range. 
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3.6.3 Synthetic procedures 
Synthesis of 2-(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (DMP) 
Dodecane thiol (4.00 g, 4.73 mL, 19.76 mmol) was added dropwise to a stirred 
suspension of K3PO4 (4.20 g, 19.76 mmol) in acetone (60 mL) over 25 minutes. CS2 
(4.10 g, 3.24 mL, 53.85 mmol) was added and the solution turned bright yellow. After 
stirring for ten minutes 2-bromo-2-methylpropionic acid (3.00 g, 17.96 mmol) was 
added and a precipitation of KBr was noted. After stirring for 16 hour, the solvent was 
removed under reduced pressure and the residue was extracted into CH2Cl2 (2 × 200 
mL) from 1M HCl (200 mL). The organic extracts were washed with water (200 mL) 
and brine (200 mL) and further dried over MgSO4. The solvent was removed under 
reduced pressure and the residue was purified by recrystallization in hexane. 
1H NMR (300 MHz, CDCl3) ppm: 3.31 (2H, t, J12-11= 7.34 Hz, H12); 1.76 (6H, s, H13); 
1.70 (2H, m, H11); 1.41 (2H, m, H10); 1.28 (16H, br. s, H2-9); 0.90 (3H, t, J1-2= 6.79 Hz, 
H1). 
13C NMR (500 MHz, CDCl3) ppm: 220.98 (C13); 176.63 (C16); 55.44 (C14); 37.09 
(C12); 31.92, 29.64, 29.56, 29.45, 29.35, 29.24, 29.11, 22.70 (C2-9); 28.96 (C10); 27.81 
(C11); 25.27 (C15); 14.13 (C1). 
IR cm-1: 2916 (alkyl-H stretch); 1710 (C=O stretch); 1068 (S-(C=S)-S stretch). 
HRMS (ESI +) m/z: 365.1632 [M+H]+; expected 365.1637 (C17H33O2S3). 
 
  
135 
 
Polymerization of N-isopropylacrylamide using 2-
(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (DMP) 
Polymers with three different molecular weights were synthesised in typical procedure. 
N-isopropylacrylamide (1 g, 8.84 mmol), 2-(dodecylthiocarbonothioylthio)-2-
methylpropanoic acid (64.45 mg, 177 mol), and 4,4'-azobis(4-cyanovaleric acid) 
(ACVA) (9.9 mg, 35.3 mol) were dissolved in methanol/toluene (1 : 1; 4mL) in a 
glass vial containing a stir bar giving [monomer] : [chain transfer agent] : [initiator] = 
50 : 1 : 0.2. Mesitylene (150 L) was added as an internal reference and the mixture 
was stirred (5 mins). An aliquot of this starting mixture was removed for 1H NMR 
analysis. The vial was fitted with a rubber septum and degassed by bubbling with 
nitrogen gas (30 mins). The vial was then placed in an oil bath thermostated at 70 °C. 
After 35 minutes, the reaction mixture was opened to air and quenched in liquid 
nitrogen. An aliquot was removed and conversion determined by 1H NMR. The 
remainder was precipitated into diethyl ether (45 mL). The polymer was re-
precipitated and purified from THF to diethyl ether three times. The product was 
purified three times by precipitation from toluene into diethyl ether, isolated 
centrifugation, and dried under vacuum overnight to give a yellow solid. The overall 
monomer conversion was determined from the 1H NMR spectrum by measuring the 
decrease in intensity of the vinyl peaks associated with the monomer relative to 
mesitylene. Conversion (NMR): 86 %; Mn (theoretical), 5200 g mol
-1; Mn (SEC), 7100 
g mol-1; Mw/Mn (SEC), 1.10. 
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Synthesis of pentafluorophenyl 2-(dodecylthiocarbonothioylthio)-2-
methylpropanoic acid (PFP-DMP) 
2-(dodecylthiocarbonothiolythio)-2-methylpropanoic acid (0.50 g, 1.37 mmol), N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) (0.39 g, 2.05 
mmol) and 4-(dimethylamino)pyridine (DMAP) (0.25 g, 2.05 mmol) in 40 mL 
dichloromethane (DCM) was stirred for 20 minutes under N2. Pentafluorophenol (0.78 
g, 4.24 mmol) in 5 mL DCM was added. The reaction was stirred overnight at room 
temperature. The reaction was washed successively with 3 M HCl (50 mL), 1 M 
NaHCO3 (50 mL) and 0.5 M NaCl (50 mL). The reaction was then dried over MgSO4, 
filtered and then concentrated in vacuum. 
1H NMR (300 MHz, CDCl3) ppm: 3.24 (2H, t, J12-11= 7.70 Hz, H12); 1.79 (6H, s, H13); 
1.65 (2H, m, H11); 1.32 (2H, m, H10); 1.18 (16H, br. s, H2-9); 0.81 (3H, t, J1-2= 6.42 Hz, 
H1). 
13C NMR (500 MHz, CDCl3) ppm: 219.94 (C13); 169.62 (C16); 55.41 (C14); 37.17 
(C12); 31.92, 29.63, 29.55, 29.43, 29.35, 29.26, 29.09, 22.70 (C2-9); 28.92 (C10); 27.82 
(C11); 25.43 (C15); 14.12 (C1). 
19F NMR (300 MHz, CDCl3) ppm: -151.5 (d, 2F, ortho F); -157.7 (t, F, para F); -162.4 
(t, 2F, meta F). 
IR cm-1: 2923 (CH2); 1779 (C6F5C=O); 1073 (S-(C=S)-S). 
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Polymerization of hydroxyethylacrylamide usting pentafluorophenyl 2-
(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (PFP-DMP)  
In a typical reacation, hydroxyethylacrylamide (HEA) (0.50 g, 4.34 mmol), 
pentafluorophenyl 2-(dodecylthiocarbonothiolythio)-2-methylpropanoic acid (PFP-
DMP) (0.154 g, 0.289 mmol), 4,4'-azobis(4-cyanovaleric acid) (ACVA) (0.0162 g, 
0.058 mmol) were dissolved in 50 : 50 toluene : methanol (4 mL). Mesitylene (150 
L) was added as an internal reference. An aliquot was taken for NMR analysis in 
MeOD. The solution was degassed under N2 for 30 mins. The reaction was stirred at 
70 °C for 90 mins. An aliquot was taken for NMR analysis for NMR analysis in MeOD. 
The reaction was rapidly cooled in liquid nitrogen and precipitaed into diethyl ether. 
The polymer was reprecipitaed into diethyl ether from methanol twice to yield a 
yellow polymer product which was dried under vacuum. Conversion (NMR): 93 %; 
Mn (theoretical), 2100 g mol
-1; Mn (SEC), 4800 g mol
-1; Mw/Mn (SEC), 1.10. 
 
End group modification of PFP-polyhydroxyethylacrylamide using 
galactosamine 
In a typical reacation, PFP-pHEA (50 mg, 0.024 mmol), galactosamine (25.2 mg, 
0.117 mmol) were dissolved in 5 mL DMF with 0.05 M triethylamine (TEA). The 
reaction was stirred at 50 °C for 16 hrs. The polymer was precipitated into diethyl 
ether from methanol three times and dried under vacuum. IR indicated loss of C=O 
stretch corresponding to the PFP ester. 
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General procedure for the synthesis of polymer-coated gold nanoparticles 
Approximately 1 mg of the pNIPAM or desired thiol-terminated pHEA-Gal was added 
to a microcentrifuge tube, and dissolved in 100 L of high-purity water. For the thiol-
terminated pNIPAM, ethanolamine (50 mol equiv of pNIPAM) was also added. 900 
L of the citrated-stabilized gold nanoparticle solution was added to this tube (40 nm: 
0.296 mmol L-1, 60 nm: 0.288 mmol L-1 total gold concentration), which was then 
agitated 30 mins in the absence of light. To remove excess polymer, the particles were 
centrifuged and following careful decantation of the supernatant, the particles were 
then re-dispersed in 1 mL of high-quality water and the centrifugation-resuspension 
process repeated for a total of 3 cycles. After the final cycle the particles were 
dispersed in 1 mL of high-quality water for future use. Assuming complete 
incorporation of the citrate coated gold particles into the final polymer coated particles 
the total concentration of gold in the final solution was 0.296 mmol L-1, 0.058 mg mL-
1 and 0.288 mmol L-1, 0.057 mg mL-1. 
 
Gold nanoparticle functionalisation using a mixture of pHEA-Gal and pNIPAM 
(9 : 1 molar ratio) 
100 L of total polymer solution with different molar ratio between pHEA-Gal (0.90 
mg, 0.43 mol, 90 L) and thiol-terminated DP50 pNIPAM (0.25 mg, 0.048 mol, 10 
L) and was added to 900 L of 60 nm gold nanoparticles. Left for 30 minutes at room 
temperature and centrifuged to remove any attached polymer and resuspended in water. 
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Lectin induced aggregation studies by absorbance 
A stock solution of the lectin was made up (0.1 mg mL-1 for SBA) in 10 mM HEPES 
buffer with 0.15 M NaCl, 0.1 mM CaCl2 and 0.01 mM MnCl2. 25 L serial dilution 
was made up in the same buffer in a 96-well micro-titre plate. 25 L of the multi-
polymer functionalised gold nanoparticle were added to each well. Initial and after 30 
minutes, both absorbance spectrum were recorded from 450 nm – 700 nm with 10 nm 
intervals at 20 °C and 40 °C, respectively. 
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Chapter 4 
4. Triggerable Multivalent Glyco-
Nanoparticles for Probing Carbohydrate-
Carbohydrate Interactions 
 
4.1 Chapter summary 
In this chapter, multivalent glyco-nanostructures are developed where the surface-
expression of the disaccharide lactose can be triggered by an external stimulus by the 
selective collapse of a response polymer ‘gate’. A gold nanoparticle core enables 
colourimetric signal outputs to be generated upon aggregation of the particles which 
enables two different carbohydrate-carbohydrate interactions to be probed, unlike the 
more commonly used carbohydrate-protein interactions. 
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4.2 Abstract 
Carbohydrate-carbohydrate interactions, CCIs, are crucial in biological signaling but 
have much lower affinities than carbohydrate-protein interactions. Multivalent 
presentation of carbohydrates is essential to study CCIs to overcome their extremely 
low affinity, which is lower than even carbohydrate-lectin interactions. Here we use 
multivalent glyco-nanostructures where the expression of lactose at the particle 
surface is ‘gated’ by an external stimulus, and a gold nanoparticle core provides 
intrinsic colourimetric signal outputs to probe the CCIs. Careful macromolecular 
engineering of a responsive polymer ‘gate’ enables the lactose moieties to be blocked, 
until a stimulus is introduced, exposing the glycan in a manner comparable to how 
nature uses enzymes to regulate glycan expression. The system was used to probe both 
Lactose-Lactose and Lactose-monosialodihexosylganglioside (GM-3) glycolipd 
interactions to demonstrate regulation and specificity. This externally addressable 
system overcomes a challenge of studying self-self-interactions, where spontaneous 
cross-linking occurs, and will enable the exploitation of CCIs for biotechnological 
applications. 
 
4.3 Introduction 
Cells from across all kingdoms of life are coated with glycans (polysaccharides, 
glycolipids, glycoproteins) which provide both internal and external cues for 
recognition, disease state, signal transduction and more.1 The protein ‘readers’ of 
glycans are termed lectins, which engage in relatively weak interactions with 
individual glycans with mM affinity.2,3 To overcome this, glycans are presented on 
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cells in a multivalent format, enabling a non-linear increases in binding affinity (often 
to < nM), termed the ‘cluster glycoside effect’4 leading to dramatic increases in 
affinity.4 Inspired by this, synthetic materials bearing multiple carbohydrates have 
been developed which also have high affinity5 and can compete for native ligands in 
anti-adhesion therapy,6-8 or as biosensors.9,10 
Whilst carbohydrate-lectin interactions have been extensively studied and a huge 
variety of tools exist to probe them, carbohydrate-carbohydrate interactions (CCI) 
where the sugars directly engage with each other are much less studied.11 Initial stages 
of cell-cell recognition are driven by glycosphingolipid CCI’s12 and the aggregation 
of marine sponges is driven by sulfated glycan CCI’s.13,14 The affinity of CCIs is 
extremely weak, even compared to carbohydrate-lectin interactions (~mM) and 
require divalent metal ions to bridge the glycans; multivalent presentation is essential 
to enable significant interaction forces to be generated.11,15,16 Murthy et al have 
synthesized lactose-functional -cyclodextrin which engages with 
monosialodihexosylganglioside (GM-3) glycolipid via a CCI to enable successful 
delivery of doxorubicin and may explain the lactose ‘trojan horse’ effect for gaining 
entry into mammalian cells.17 Dendritic and nanoparticle based systems, normally 
based on lactose have been synthesized and evaluated for CCIs.11,16,18 These extremely 
weak interactions have been measured using solution NMR,19 interfacial techniques 
such as Langmuir-Blodget18 and scanning probe microscopy20 and also by surface 
plasmon resonance (SPR).14 Seeberger and co-workers have developed multivalent 4 
nm silica glyco nanoparticles to study GM3-Gg3 interactions.16 Penades and co-
workers have used glycan-functional gold nanoparticles with SPR to demonstrate 
strong CCI multivalent effects.15 Russel and coworkers used PEG-lactose functional 
gold particles for the plasmonic detection (red-blue colour change) of CCIs,21 enable 
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simple and accessible read-outs, which have also found application in biosensing.10 
A challenge in studying CCIs is that many of these are self-self interactions, e.g. 
lactose-lactose. Therefore, it is highly desirable to prevent spontaneous interactions 
between synthetic multivalent systems, by introducing an inducible ‘trigger’ such that 
the glycan is presented with temporal, or spatial control; in Nature this is achieved by 
expression of glycosyltransferases which install the glycan as and when required, 
depending on internal/external stimuli such as disease state.22,23 There are many 
examples of stimuli-responsive polymers,24 capable of changing their form (e.g. coli-
globule transition) in response to redox,25 light26 and metal ions.27 Mastrotto et al have 
used the reversible collapse of poly(N-isopropyl acrylamide) to present folate on 
particle surfaces for cellular delivery.28 Won et al demonstrated responsive polymers 
can provide a reversible steric ‘shield’ to present glycans at gold nanoparticle surfaces 
ensuring lectin binding only occurs when the system is activated.29  
Herein we describe dynamic nanomaterials where the surface expression of glycans 
can be externally triggered, to induce a carbohydrate-carbohydrate interaction. We 
show that polymeric gates can effectively block a (shorter) polymer bound glycan and 
present it at the surface of a gold nanoparticle on demand, and exploit the coupling of 
gold particle SPRs to monitor the interaction colourmetrically under the control of a 
small temperature change. By engineering an inducible trigger, these systems will 
facilitate the study and exploitation of CCIs in biotechnological fields. 
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4.4 Result and Discussion 
Our design principle requires a non-responsive polymer bearing the glycans, and a 
responsive polymer to act as the reversible gate, poly(hydroxyethyl acrylamide) 
(pHEA) and poly(N-isopropylacrylamide) (pNIPAM) were respectively chosen for 
this.29 pNIPAM was polymerized using CTA-2 2-(dodecylthiocarbonothioylthio)-2-
methylpropionic acid). pHEA was polymerized using CTA-1 (pentafluorophenyl 2-
(dodecylthiocarbonothioylthio)-2-methylpropionic acid) which enables installation of 
amino-glycans onto the chain-end by displacement of the reaction PFP group.30 PFP-
pHEA15 was quantitatively functionalised by addition of either 2-amino-2-deoxy-D-
galactose (GalNH2) or -1-aminopropyl,D-lactose (LacNH2), which was synthesized 
in 4 step procedure from lactose using a well-defined method similar to that already 
reported.31, 32 
 
Scheme 4.1 Synthesis of a non-responsive/responsive polymer. A) Synthesis of 
glycosylated pHEA; B) Synthesis of pNIPAM. Initiator = 4,4′-Azobis(4-cyanovaleric 
acid). 
 
4 Steps
CTA-1/ACVA
or
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A
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H
n
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n
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Trithiocarbonate RAFT end-groups of pNIPAM undergo reaction with nucleophiles  
(e. g. ethanolamine) to transform to thiol functionality and addition of the glycans also 
results in cleavage of the RAFT agent of pHEA producing a terminal thiol suitable for 
conjugation to the surface of citrate-stabilized gold nanoparticles due to the high 
affinity between sulfur and gold as shown in Scheme 4.2. Finally, both non-responsive 
glycopolymer and temperature responsive polymer were conjugated on particles 
together to obtain the gating accessibility of glycans in certain circumstances. 
 
Scheme 4.2 Concept of gated glycoparticles. A) Homo-and hetero-genous coating of 
gold nanoparticles; B) concept of thermo-responsive polymer gate to control 
expression of lactose at the nanoparticle surface. 
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To ensure that the glycan-bearing polymer (pHEA) can be effectively ‘hidden’ by the 
responsive polymer (pNIPAM) the targeted degrees of polymerization were 15 and 50 
respectively.29 SEC analysis suggest slightly higher molecular weights than NMR for 
the theoretical molecular weight of pHEA and pNIPAM. These two different polymers 
were well-defined, with a narrow dispersity (Đ <1.1) as shown in Table 4.1 and Figure 
4.1. 
Table 4.1 Polymer synthesis and characterisation. 
Polymer [M]:[CTA]:[I] 
(-) 
Conversion(a) 
(%) 
Mn(Theo)(b) 
(g mol-1) 
Mn(SEC)(c) 
(g mol-1) 
Mw/Mn 
(-) 
CP(d) 
(C) 
PFP-pHEA15 15:1:0.2 93 % 2100 4800 1.10 - 
pNIPAM50 50:1:0.2 86 % 5200 7100 1.10 38 
pNIPAMxxx / pHEAxxx = poly(N-isopropylacrylamide) / poly(hydroxyethyl acrylamide) 
where average degree of polymerization indicated by xxx; (a) determined by 1H NMR; 
(b) From [M]:[CTA] and 1H NMR; (c) Compared to PS standards; (d) cloud point 
determined by turbimimetry at 1.0 mg mL-1. 
 
14.5 15.0 15.5 16.0 16.5 17.0
0.0
0.2
0.4
0.6
0.8
1.0
N
o
rm
a
li
s
e
d
 R
I 
R
e
s
p
o
n
s
e
Retention Time (mins)
 pNIPAM
50
 PFP-pHEA
15
 
Figure 4.1 SEC analysis of polymers. 
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IR spectroscopies in Figure 4.2 confirmed installation of the two different glycan into 
pHEA. The disappearance of C=O stretch peak (at around 1750 cm-1) corresponding 
to the carbonyl of PFP end-group shows that the pentafluorophenol end-group is 
removed successfully after reaction with galactosamine/lactosamine by an amide bond. 
 
 
Figure 4.2 Infrared spectra of PFP-pHEA15 (black), GalNAc-pHEA15 (red) and Lac-
pHEA15 (blue). Box indicate region where PFP ester group would be found. 
 
60 nm gold nanoparticles (Au60) were coated with the indicated (Figure 4.3 and Table 
4.2) ratios of each polymer to generate particles bearing either pure glycan coatings, 
or mixed glycan/responsive polymer coatings. The resulting nanoparticles were 
purified from excess polymer by repeated centrifugation/resuspension cycles and 
characterised by UV-Visible spectroscopy and dynamic light scattering. Polymer 
coating was confirmed by the shift of the SPRMAX peak to red shifted longer 
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wavelength. Dynamic light scattering showed an increase in diameter from 58 to ~ 70 
nm upon particle coating with mono-modal distributions obtained. TEM analysis was 
also employed to provide the polymer coating directly, TEM images clearly show the 
presence of an approximately 3 nm polymer ‘halo’ surrounding each individual gold 
nanoparticle (Figure 4.3C/D). 
 
 
Figure 4.3 Characterisation of polymer functionalised 60 nm gold nanoparticle A) 
UV-Vis spectra; B) DLS analysis; C) Transmission electron microscope (TEM) image 
of Lac-pHEA15 (9) / pNIPAM50 (1) coated 60 nm gold nanoparticles at 20 
oC showing 
polymer ‘halo’; D) at 40 oC in presence of Ca2+ when aggregated. 
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Table 4.2 Nanoparticle characterisation. 
Particle SPR 
[nm](a) 
Diameter 
[nm](b) 
Cloud 
point  
[°C](c) 
Zeta-
potential 
[mV](d) 
Au60 534 58 - -41(e) 
pNIPAM50@Au60 538 75 59 -15 
Lac-pHEA15(9)/pNIPAM50(1)@Au60 538 67 52 -14 
Lac-pHEA15@Au60 537 66 - -11 
GalNAc-pHEA15@Au60 537 66 - -9 
(a) Surface plasmon resonance band; (b) determined by DLS; (c) determined in water 
by UV-Vis spectroscopy; (d) conducted in HEPES buffer unless noted; (e) conducted 
in water. Total gold particle concentration (0.0255 mg mL-1). 
 
UV-Vis spectroscopy was used to determine the cloud point (CP) of homopolymer and 
polymer coated nanoparticles in different media (pure water, HEPES buffer, 100 mM 
of Ca2+ in HEPES) defined as being the point of 50 % transmittance. All particles CP 
data are shown in turbidity curves of Figure 4.4 and Table 4.2. (Note, the cloud point 
is distinct from, and is the macroscopic effect associated with, an LCST). pNIPAM50 
showed a cloud point of 38 C at 1 mg mL-1. It is notable that once pNIPAM 
immobilised on the nanoparticle the actual transition temperature will vary,33 hence a 
full concentration dependant study on this well-known polymer was not undertaken.25 
pNIPAM50 containing particles had cloud points above 50 C, this is sufficiently high 
degree to prevent the false positive signal (unwanted particle aggregation). Actual 
pNIPAM50 chain collapse occurs around 38 
oC, slightly below at certain reaction 
temperature (40 oC) for carbohydrate-carbohydrate interaction. The desired 
temperature will be safely placed between room temperature and Lac-
pHEA15/pNIPAM50 coated particle’s CP (52 °C). This is essential for the present work 
and all CP value shown here represents macroscopic aggregation.33 
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Figure 4.4 Turbidimetry scans (absorbance at 700 nm) of pure pNIPAM50 (1.0 mg 
mL-1) and polymer functionalised gold nanoparticles (0.0255 mg mL-1) in different 
solution. 
 
There was also a corresponding increase in the zeta potential (less negative) of 
particles in different media as shown in Figure 4.5 and Table 4.3. Citrate stabilized 
bare gold nanoparticle in the pure water has strong negative charge less than -40 mV 
and negative charge of particles was slightly increased of homogeneous or 
heterogeneous polymer coating. These values are significantly increased in HEPES 
buffer solution with various salt ions, moreover zeta potential of polymer coated gold 
nanoparticles are increased higher again in HEPES solution with 100 mM of Ca2+ due 
to decrease of electrostatic repulsion force by salt screen effect. The particles overall 
had a net-negative charge as is widely reported for coating by this method.34 However, 
there was no significant shift in UV-vis absorption peaks even after hours incubation 
(data not shown), indicating the particles remain stable in buffered saline solutions 
with high concentration of Ca2+. 
154 
 
0
-10
-20
-30
-40
Ca
2+
(100mM) HEPESHEPES
 Bare gold 60nm
 pNIPAM
50
@Au
60
 Lac-pHEA
15
(9)/pNIPAM
50
(1)@Au
60
 Lac-pHEA
15
@Au
60
 GalNAc-pHEA
15
@Au
60
Z
e
ta
-p
o
te
n
ti
a
l 
(m
V
)
Solution of particle
Water
 
Figure 4.5 Zeta-potential analysis of nanoparticles in water, in HEPES without Ca 2+, 
and in HEPES containing Ca2+ (100 mM). Polymer functionalised gold nanoparticles 
(0.0255 mg mL-1). 
 
Table 4.3 Solution properties of polymer coated gold nanoparticles. 
Particle Cloud point Ca2+ 
[°C] a) 
Zeta-
potentialwater  
[mV] b) 
Zeta-
potential Ca2+  
[mV] c) 
Bare gold 60 nm - -41 - 
pNIPAM@Au60 42 -38 -7 
Lac-pHEA(9)/pNIPAM(1)@Au60 45 -37 -5 
Lac-pHEA@Au60 - -35 -5 
GalNAc-pHEA@Au60 - -23 -3 
a)Cloud point was measured in HEPES buffer containing 100 mM Ca2+ upon heating 
from 25 °C to 80 °C, 0.0255 mg mL-1 total particle concentration. The cloud point of 
particles defined as being the point of 50% transmittance by UV-Vis spectroscopy; 
Zeta-potential of nanoparticles measured in b)water and c)HEPES buffer containing 
100 mM Ca2+. 
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With this panel of nanoparticles bearing both responsive/non-responsive units and two 
different glycans to hand, control experiments were undertaken to demonstrate glycan-
driven interactions at the particle surface. Lac-pHEA15@Au60 and GalNac-
pHEA15@Au60 (i.e. non-responsive homogenous coatings) were exposed to 0.1 to 100 
mM of Ca2+. Ca2+ is the primary divalent ion which bridges glycans of appropriate 
stereochemistry to enable the CCI.35,36 Following 30 min incubation Lac-
pHEA@Au60 showed distinct shifts in its UV-Visible spectra with the SPRMAX 
decreasing and Abs700 increasing, consistent with cross-linking, Figure 4.6.
37,38 
Conversely, addition of Ca2+ to GalNAc-pHEA15@Au60 showed very minor spectral 
changes with essentially zero aggregation. In order to ensure specificity of particles, 
the interaction of Ca2+ with two different particles was evaluated by plotting the Abs700 
against Ca2+ concentration. Figure 4.6C shows Lac-pHEA15@Au60 exhibiting a clear 
dose-dependent binding isotherms in the Ca2+ concentration range. 
 
Figure 4.6 Calcium and lectin triggered aggregation of homogenous glyco-
nanoparticles. A) Lac-pHEA15@Au60 with Ca
2+; B) GalNAc-pHEA15@Au60 with 
SBA; C) Binding Isotherm with Ca2+ gradient. 
450 500 550 600 650 700
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
A
b
s
o
rb
a
n
c
e
 (
n
o
rm
a
lis
e
d
)
Wavelength (nm)
[Ca2+]
0.1 – 100 mM
450 500 550 600 650 700
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
A
b
s
o
rb
a
n
c
e
 (
n
o
rm
a
lis
e
d
)
Wavelength (nm)
[Ca2+]
0.1 – 100 mM
A B
0 20 40 60 80 100
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0  Lac-pHEA @ Au60nm
 GalNAc-pHEA @ Au60nm
N
o
rm
a
lis
e
d
 A
b
s
7
0
0
 [Ca
2+
] (mM)
C
Lac-pHEA@Au60
GalNAc-pHEA@Au60
SH
SH
T > LCST
Target lectin
SH
SH
T > LCST
Target lectin
156 
 
TEM analysis confirmed these observations (Figure 4.7). TEM images of Lac-pHEA15 
coated gold nanoparticles were acquired by simple preparation method. A drop of 
nanoparticle samples solution with or without 100 mM of Ca2+ was deposited onto a 
copper grid and the water was evaporated under room temperature until fully dried 
without any staining. Figure 4.7A shows spherical gold nanoparticles were well-
dispersed due to the colloidal stability by polymer coating without Ca2+. By contrast, 
there is a clear aggregated gold nanoparticles complex where containing Ca2+ as 
shown in Figure 4.7B. GalNAc particles does not undergo self-CCIs and hence ruled 
out non-specific interactions due to the changes in ionic strength of the buffers. 
 
 
Figure 4.7 Calcium and lectin triggered aggregation of homogenous glyco-
nanoparticles. TEM analysis of Lac-pHEA15@Au60 A) without and B) with Ca
2+. 
Scale bar = 500 nm. 
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To further corroborate the link between glycan presentation and aggregation, a lectin-
mediated (carbohydrate-protein) interaction was also studied. Soy bean agglutinin 
(SBA) was chosen as it has high affinity for GalNAc but lower affinity for lactose (i.e. 
opposite response to CCI expected).39 A serial dilution of SBA was added to both 
nanoparticles from 10 – 100 nM and UV-Vis spectra recorded (Figure 4.8). SBA 
requires some calcium to be present in the binding mix, but at concentrations which 
did not cause CCI aggregation. Lac-pHEA15@Au60 showed no aggregation but 
GalNAc-pHEA15@Au60 underwent strong dose-dependent binding to SBA with a 
decrease in SPRMAX and increase in ABS700. These control experiments confirmed the 
differential presentation of glycans on the nanoparticle surface and the highly specific 
nature of the both the CCI and lectin mediated interactions and that the subtle end-
group modifications provide sufficient density on the particle surface to induce a 
cluster-glycoside enhancement. 
 
Figure 4.8 Calcium and lectin triggered aggregation of homogenous glyco-
nanoparticles. A) Lac-pHEA15@Au60 with SBA; B) GalNAc-pHEA15@Au60 with 
SBA; C) Binding isotherm with SBA gradient. 
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For further control experiment, Mn2+ was used, also a divalent cation which can drive 
CCI. Similar results were obtained as we expected (Figure 4.9), the Lac-
pHEA15@Au60 show a clear dose-dependent response with remarkable changes in the 
UV-vis spectra and binding isotherms in the Mn2+ concentration range, whereas Gal-
pHEA15@Au60 do not show any significant changes from both data. This result 
indicating that a divalent cation has a selectivity toward lactose terminal glycans. 
 
Figure 4.9 UV-Vis traces of different glycol-nanoparticle in presence of serial dilution 
of manganese (Mn2+) after 30 minutes incubation at room temperature. A) Lac-
pHEA15@Au60 with Mn
2+; B) GalNAc-pHEA15@Au60; C) Binding isotherm with 
Mn2+ gradient. 
 
The above data demonstrated that Lac-Lac CCIs could be induced on polymer-coated 
nanoparticle surfaces but also highlights the challenge of their study; when lactose-
functional materials are placed in the biological buffers spontaneous self-aggregation 
is always going to occur. This complicates detailed studies, especially in cell based 
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assays as the expression of lactose is static, not controllable, but has been reported to 
drive cell uptake by unknown mechanisms.17 To evaluate steric gating to mediate these 
interactions Lac-pHEA15 : pNIPAM50 ratio 9 : 1 @Au60 was monitored for calcium-
mediated aggregation at 20 C. At this temperature, the pNIPAM is fully extended and 
provides a steric block to CCIs, preventing aggregation even at 100 mM Ca2+, Figure 
4.10. Time-dependant studies by monitoring Abs700 showed only a very slow change. 
TEM revealed no evidence of aggregation for both in the presence and absence of Ca2+ 
in particle solution. Hence it can be seen that just 10 mol% of pNIPAM on the particle 
surface can sterically block CCIs, and is ‘gate closed’. 
 
Figure 4.10 Temperature–controlled gating off lactose expression at Lac-pHEA15 : 
pNIPAM50 ratio 9 : 1 @Au60 surfaces. Ca
2+ addition at 20 C showing full UV-vis A) 
and time-dependence B). Ca2+ addition at 40 C showing full UV-Vis C) and time-
dependence D). 
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Identical experiments as above were conducted, but this time at 40 C which is above 
the chain collapse temperature of pNIPAM, but below the threshold for them to 
aggregate (avoiding false positives, see Table 4.2), Figure 4.11C/D. Addition of Ca2+ 
lead to a clear increase in Abs700 and time-dependant monitoring of these showed rapid 
aggregation significantly faster and to a greater extent than for at 20 C. TEM 
confirmed the formation of aggregates in the presence of Ca2+ at 40 oC, but that in the 
absence of Ca2+ (even at 40 C) there were no non-specific particle-particle 
interactions. It should be highlighted that this is the first example of using an external 
trigger (temperature) to control a CCI interaction and provides a dynamic tool for 
studying this area of glycoscience. 
 
Figure 4.11 TEM analysis of Lac-pHEA15(9)/pNIPAM50(1)@Au60 to prove need for 
both collapse of the steric block and Ca2+. 20 ºC without A) and with B) 100 mM Ca2+. 
40 ºC without C) and with D) 100 mM Ca2+. 
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To further demonstrate the potential utility of these responsive nanoparticles, an assay 
was devised to mimic cell-surface hetero-CCI interactions; namely lactose-GM-3.40 In 
short, a polystyrene plate was modified by physiosorption of 
monosialodihexosylganglioside (GM-3) glycolipid to create a cellular membrane 
mimic substrate. This was then incubated with both static, and dynamic nanoparticles 
and binding evaluated by UV-Vis and high-resolution scanning electron microscopy 
(SEM) after washing, Scheme 4.3.  
 
Scheme 4.3 Schematic illustration of experimental concept and GM-3 structure. 
 
Due to the low concentration (a monolayer) low UV-Vis signals were obtained but the 
presence of the SPR peak at ~ 550 nm was present when Lac-pHEA@Au60 was 
incubated with calcium at 20 ºC, but no SPR peak was seen for the other static particles 
Figure 4.12A. Figure 4.12B shows the dynamic particles, Lac-
pHEA15(9)/pNIPAM50(1)@Au60, at both 20 and 40 ºC showing Nanoparticles were 
only bound at the higher temperature, when the gate is ‘open’. SEM corroborated the 
observations from UV-Vis. Figure 4.12C/D show that for the static nanoparticles 
significant capture of particles by GM-3 only occurred for lactose not GalNAc 
functional particles, demonstrating the specific nature of the interaction. Figure 4.12E 
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show the dynamic nanoparticles with ‘gate closed’ at 20 ºC (no binding) and Figure 
4.12F with ‘gate open’ at 40 ºC with significant Lac-GM-3 interactions occurring. This 
model system clearly demonstrates the potential for dynamic glycoparticles for 
cell/interfacial based assays to probe CCI function. 
 
Figure 4.12 Interactions between glyco nanoparticles and GM-3 functional surface. 
UV-Vis analysis of GM-3 surface after incubation with particles, A) with ‘static’ 
nanoparticles at fixed temperature and B) with dynamic nanoparticles, in presence of 
Ca2+ at variable temperatures. SEM’s of C) Lac-pHEA15@Au60 at 20 ºC; D) GalNAc-
pHEA15@Au60 20 ºC; E) Lac-pHEA15(9)/pNIPAM50(1)@Au60 at 20 ºC; F) Lac-
pHEA15(9)/pNIPAM50(1)@Au60 at 40 ºC. False colour applied to SEM for clarity 
(non-coloured images are presented in the appendix 1). 
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4.5 Conclusions 
Herein we demonstrate the first example of stimuli-responsive, ‘triggerable’ 
multivalent glyconanoparticles for the study of carbohydrate-carbohydrate 
interactions, unlike the widely studied carbohydrate-lectin interactions. At the surface 
of 60 nm gold nanoparticles non-responsive poly(hydroxyethyl acrylamide) was used 
to anchor lactose and responsive poly(N-isopropylacrylamide) which can undergo 
thermally-triggered chain collapse also added. The responsive polymer, below its 
transition temperature, blocked any lactose-lactose interactions via steric shielding, 
but upon application of a temperature stimulus the chain collapses and exposes the 
lactose. Lactose-lactose interactions could then be measured, as a function of calcium 
concentration, which is essential for this process. The polymer molecular weights were 
tuned such that upon carbohydrate-carbohydrate interaction, the gold nanoparticles 
will aggregate, leading to changes in their surface plasmon resonance band and hence 
providing a read-out of the interaction by UV-Vis spectroscopy. The hetero Lac-GM-
3 interaction was also probed by this method, using a complimentary surface-binding 
assay to mimic a cell-surface interaction. This new method enables temporal control 
of when the glycans are expressed on the nanoparticle surface, comparable to 
enzymatic control in Nature. Crucially, unwanted spontaneous carbohydrate-
carbohydrate interactions are entirely prevented, ensuring that recognition (and hence 
aggregation) only occurs under the operators control and hence will facilitate the study 
and exploitation of multivalent carbohydrate-carbohydrate interactions, which are 
underrepresented compared to carbohydrate-lectin interactions. 
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4.6 Experimental Section 
4.6.1 Materials 
All chemicals were used as supplied unless otherwise stated. Methanol, hexane, 
hydrochloric acid, dichloromethane, toluene, acetone, tetrahydrofuran, chloroform, 
ethyl acetate, petroleum ether and diethyl ether were purchased from Fisher Scientific 
at laboratory reagent grade. Deuterochloroform (99.9 atom % D), deuteromethanol 
(99.5 atom % D), deuterium oxide (99.9 atom % D), 4,4'-azobis(4-cyanovaleric acid) 
(> 97.0 %), dodecane thiol (≥ 98.0 %), potassium phosphate tribasic (reagent grade, ≥ 
98.0 %), carbon disulfide (≥ 99.9 %), 2-bromo-2-methylpropionic acid (98.0 %), N-
isopropylacrylamide (97.0 %), hydroxyethylacrylamide (97.0 %), N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (98.0 %), N,N-
dimethylformamide (99.8%), 3-bromo-1-propanol (97.0 %), boron trifluoride diethyl 
etherate (46.5 % BF3 basis), sodium bicarbonate (99.5 %), sodium chloride (99.5 %), 
sodium azide (99.5 %), calcium chloride (≥ 96.0 %), manganese(II) chloride (99.0 %), 
ethanolamine (≥ 99.0 %), magnesium sulfate (≥ 99.5 %) and mesitylene (analytical 
standard) were all purchased from Sigma-Aldrich. 4-(Dimethylamino)pyridine 
(99.0 %), pentafluorophenol (99.0 %), trimethylamine (99.0 %) and sodium 
methoxide solution(30 wt. % in methanol) were purchased from Acros. Clear, 
polystyrene, flat-bottom, half-area 96-well microtiter plates and 96-well high binding 
microtitre plates were purchased from Greiner Bio-one. 10 mmol HEPES buffer 
containing 0.15 M NaCl, 0.1 mM CaCl2 and 0.01 mM MnCl2 (pH 7.5, HEPES) was 
prepared in 200 mL of milli-Q water (with a resistance of 18.2 M cm). Pre 
formulated phosphate buffered saline tablets dissolved in 200 mL of milli-Q water 
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(with a resistance of 18.2 M cm) to give 0.137 NaCl, 0.0027 M KCl, 0.01 M 
Na2HPO4, 0.0018 M KH2PO4 and pH = 7.4. Gold nanoparticle solutions for 60nm 
(0.288 mmol L-1) were purchased from BBI Solutions. Amberlite IR-120 hydrogen 
form, ion exchange resin was purchased from Alfa Aesar. Soybean Agglutinin (SBA) 
was purchased from Vector Labs. D-Galactosamine hydrochloride, -D-Lactose 
octaacetate and GM-3-Ganglioside were purchased from Carbosynth Ltd. 
 
4.6.2 Analytical and physical methods 
1H, 13C and 19F NMR spectra were recorded for analysis of monomer conversions and 
polymer compositions on Bruker HD-400 and HD-500 spectrometer using deuterated 
solvents obtained from Sigma-Aldrich. All chemical shifts are reported in ppm () 
relative to tetramethylsilane (TMS). FTIR spectra were acquired using a Bruker Vector 
22 FTIR spectrometer with a Golden Gate diamond attenuated total reflection cell. A 
total 64 (or 128) scans with resolution of 4 cm-1 were collected. Samples were pre-
dried as a thin film for FTIR analysis. SEC analysis was conducted on Varian 390-LC 
MDS system equipped with a column, two PL-AS RT/MT auto sampler, a PL-gel 3 
mm (50 × 7.5 mm) guard column, two PL-gel 5 mm (300 × 7.5 mm) mixed-D columns 
using dimethylformamide (DMF) with 1 mg mL-1 LiBr at 50 °C as the eluent at a flow 
rate of 1.0 mL min-1. The GPC system was equipped with ultraviolet (UV) (set at 280 
nm) and differential refractive index (DRI) detections. Narrow molecular weight 
poly(methyl methacrylate) (PMMA) standards (200-1.0 × 106 g mol-1) were used for 
calibration using a second order polynomial fit. Polymer solutions at 1 mg mL-1 were 
prepared in the eluent and filtered through 0.45 mm filters prior to injection. UV-vis 
spectra were recorded in a disposable cuvette using a Cary 60 UV-vis spectrometer 
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from Agilent at 25 °C. Lower critical solution temperatures of free PNIPAM and 
pNIPAM nanoparticles were also analyzed using an Agilent Cary 60 UV-vis 
spectrometer equipped with a temperature controller at 700 nm with a heating/cooling 
rate of 1 °C min-1. The cloud point of pNIPAM and pNIPAM nanoparticles were 
determined by normalising the turbidimetry curve such that the values were in the 
range of 0 to 1, and the transition temperature was defined as being the temperature 
corresponding to a normalised absorbance of 0.5. A polymer concentration of 1.0 mg 
mL-1 was used in all experiments. DLS and Zeta potential measurements were 
performed using a Nano-Zs from Malvern Instruments, UK running DTS software (4 
mW, He-Ne laser,  = 633 nm) and an avalanche photodiode (APD) detector. The 
scattered light was measured at an angle of 173° for DLS measurement. The 
temperature was stabilized to ± 0.1 °C of the set temperature. All samples were 
prepared at the concentration of 0.051 mg mL-1 gold nanoparticles. Hydrodynamic 
diameter were determined using the manufacturer’s software. Absorbance 
measurements of the nanoparticles incubated with lectin were recorded on a BioTek 
SynergyTM HT multi-detection microplate reader obtained using Gen5 1.11 multiple 
data collection and analysis software. The size and morphology of the synthesized 
gold nanoparticles and polymer coated gold nanoparticles were estimated by JEOL 
2100FX transmission electron microscopy (TEM) at an accelerating voltage 200 kV. 
A drop of sample solution was deposited onto a copper grid and the water was 
evaporated under air. No staining was applied. Scanning Electron Microscopy (SEM): 
The samples were contacted to the stub using silver paint for SEM analysis. They were 
then carbon coated to provide a thin conductive covering in the region of a few nm. 
They were imaged using a Zeiss Gemini 500 SEM, using a 5 keV beam and the in-
Lens detector. 
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4.6.3 Synthetic procedures 
Synthesis of 2-(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (DMP) 
Dodecane thiol (4.00 g, 4.73 mL, 19.76 mmol) was added dropwise to a stirred 
suspension of K3PO4 (4.20 g, 19.76 mmol) in acetone (60 mL) over 25 minutes. CS2 
(4.10 g, 3.24 mL, 53.85 mmol) was added and the solution turned bright yellow. After 
stirring for ten minutes 2-bromo-2-methylpropionic acid (3.00 g, 17.96 mmol) was 
added and a precipitation of KBr was noted. After stirring for 16 hour, the solvent was 
removed under reduced pressure and the residue was extracted into CH2Cl2 (2 × 200 
mL) from 1M HCl (200 mL). The organic extracts were washed with water (200 mL) 
and brine (200 mL) and further dried over MgSO4. The solvent was removed under 
reduced pressure and the residue was purified by recrystallization in hexane. 
1H NMR (500 MHz, CDCl3) ppm: 3.31 (2H, t, J12-11= 7.32 Hz, H12); 1.76 (6H, s, H13); 
1.70 (2H, m, H11); 1.41 (2H, m, H10); 1.28 (16H, br. s, H2-9); 0.90 (3H, t, J1-2= 6.79 Hz, 
H1). 
13C NMR (500 MHz, CDCl3) ppm: 220.97 (C13); 176.62 (C16); 55.43 (C14); 37.09 
(C12); 31.92, 29.64, 29.56, 29.45, 29.35, 29.24, 29.11, 22.70 (C2-9); 28.96 (C10); 27.81 
(C11); 25.27 (C15); 14.13 (C1). 
IR cm-1: 2916 (alkyl-H stretch); 1710 (C=O stretch); 1068 (S-(C=S)-S stretch). 
HRMS (ESI +) m/z: 365.1632 [M+H]+; expected 365.1637 (C17H33O2S3). 
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Polymerization of N-isopropylacrylamide using 2-
(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (DMP) 
N-isopropylacrylamide (1 g, 8.84 mmol), 2-(dodecylthiocarbonothioylthio)-2-
methylpropanoic acid (64.45 mg, 177 mol), and 4,4'-azobis(4-cyanovaleric acid) 
(ACVA) (9.9 mg, 35.3 mol) were dissolved in methanol/toluene (1 : 1; 4mL) in a 
glass vial containing a stir bar giving [monomer] : [chain transfer agent] : [initiator] = 
50 : 1 : 0.2. Mesitylene (150 L) was added as an internal reference and the mixture 
was stirred (5 mins). An aliquot of this starting mixture was removed for 1H NMR 
analysis. The vial was fitted with a rubber septum and degassed by bubbling with 
nitrogen gas (30 mins). The vial was then placed in an oil bath thermostated at 70 °C. 
After 35 minutes, the reaction mixture was opened to air and quenched in liquid 
nitrogen. An aliquot was removed and conversion determined by 1H NMR. The 
remainder was precipitated into diethyl ether (45 mL). The polymer was re-
precipitated and purified from THF to diethyl ether three times. The product was 
purified three times by precipitation from toluene into diethyl ether, isolated 
centrifugation, and dried under vacuum overnight to give a yellow solid. The overall 
monomer conversion was determined from the 1H NMR spectrum by measuring the 
decrease in intensity of the vinyl peaks associated with the monomer relative to 
mesitylene. Conversion (NMR): 86 %; Mn (theoretical), 5200 g mol
-1; Mn (SEC), 7100 
g mol-1; Mw/Mn (SEC), 1.10. 
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Synthesis of pentafluorophenyl 2-(dodecylthiocarbonothioylthio)-2-
methylpropanoic acid (PFP-DMP) 
2-(dodecylthiocarbonothiolythio)-2-methylpropanoic acid (0.50 g, 1.37 mmol), N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) (0.39 g, 2.05 
mmol) and 4-(dimethylamino)pyridine (DMAP) (0.25 g, 2.05 mmol) in 40 mL 
dichloromethane (DCM) was stirred for 20 minutes under N2. Pentafluorophenol (0.78 
g, 4.24 mmol) in 5 mL DCM was added. The reaction was stirred overnight at room 
temperature. The reaction was washed successively with 3 M HCl (50 mL), 1 M 
NaHCO3 (50 mL) and 0.5 M NaCl (50 mL). The reaction was then dried over MgSO4, 
filtered and then concentrated in vacuum. 
1H NMR (500 MHz, CDCl3) ppm: 3.24 (2H, t, J12-11= 7.48 Hz, H12); 1.79 (6H, s, H13); 
1.67 (2H, m, H11); 1.31 (2H, m, H10); 1.19 (16H, br. s, H2-9); 0.81 (3H, t, J1-2= 6.56 Hz, 
H1). 
13C NMR (500 MHz, CDCl3) ppm: 219.94 (C13); 169.62 (C16); 55.42 (C14); 37.17 
(C12); 31.92, 29.63, 29.55, 29.43, 29.35, 29.12, 29.09, 22.70 (C2-9); 28.92 (C10); 27.82 
(C11); 25.43 (C15); 14.13 (C1). 
19F NMR (400 MHz, CDCl3) ppm: -151.54 (d, 2F, ortho F); -157.74 (t, F, para F);    
-162.34 (t, 2F, meta F). 
IR cm-1: 2923 (CH2); 1779 (C6F5C=O); 1073 (S-(C=S)-S). 
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Polymerization of hydroxyethylacrylamide usting pentafluorophenyl 2-
(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (PFP-DMP) 
In a typical reacation, hydroxyethylacrylamide (HEA) (0.50 g, 4.34 mmol), 
pentafluorophenyl 2-(dodecylthiocarbonothiolythio)-2-methylpropanoic acid (PFP-
DMP) (0.154 g, 0.289 mmol), 4,4'-azobis(4-cyanovaleric acid) (ACVA) (0.0162 g, 
0.058 mmol) were dissolved in 50 : 50 toluene : methanol (4 mL). Mesitylene (150 
L) was added as an internal reference. An aliquot was taken for NMR analysis in 
MeOD. The solution was degassed under N2 for 30 mins. The reaction was stirred at 
70 °C for 90 mins. An aliquot was taken for NMR analysis for NMR analysis in MeOD. 
The reaction was rapidly cooled in liquid nitrogen and precipitaed into diethyl ether. 
The polymer was reprecipitaed into diethyl ether from methanol twice to yield a 
yellow polymer product which was dried under vacuum. Conversion (NMR): 93 %; 
Mn (theoretical), 2100 g mol
-1; Mn (SEC), 4800 g mol
-1; Mw/Mn (SEC), 1.10. 
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Scheme 4.4 Synthesis of amino-propyl modified lactose. 
 
Synthesis of 1-(3-bromopropoxy) 2,2',3,3',4',6,6'-hepta-O-acetyl--lactoside 
-D-Lactose octaacetate (5.0 g, 7.37 mmol) was dissolved in dry CH2Cl2 (40 mL) with 
stirring. 3-bromo-1-propanol (1.54 g, 11.07 mmol) was added to a solution at rt for 1 
h under an N2 atmosphere. The reaction mixture was cooled at 0 °C, and BF3OEt2 
(3.64 mL, 29.45 mmol) was added. The reaction mixture was stirred at 0 °C for 24 h, 
and filtered over a filter paper. The filtrate was diluted with EtOAc (100 mL), and the 
organic layer was washed with satd NaHCO3 and satd NaCl, dried over MgSO4, then 
filtered and concentrated in vacuuo. The residue was purified by chromatography 
(silica gel, 1:2 pet ether-EtOAc) to give a compound 1 (1.72 g, 38%) as a colourless 
syrup. 
1H NMR (500 MHz, CDCl3) ppm: 5.37 (1H, d, J = 3.20 Hz, Gal-4); 5.23 (1H, t, J = 
9.46 Hz, Glc-3); 5.13 (1H, dd, J = 10.38, 8.09 Hz, Gal-2); 4.98 (1H, dd, J = 10.53, 3.51 
Hz, Gal-3); 4.91 (1H, dd, J = 9.31, 8.09 Hz, Glc-2); 4.54 (1H, d, J = 1.68, Glc-1); 4.51 
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(1H, d, J = 2.29, Glc-6); 4.49 (1H, d, J = 2.59, Gal-1); 4.18-4.08 (3H, m, Glc-6, Gal-
6, Gal-6); 3.99-3.95 (1H, m, -CH2-); 3.89 (1H, t, J = 7.02 Gal-5); 3.81 (1H, t, J = 9.31 
Glc-4); 3.71-3.48 (5H, m, Glc-5, -CH2-); 2.18 (3H, s, Ac); 2.15 (3H, s, Ac); 2.08 (3H, 
s, Ac); 2.07 (3H, s, Ac); 1.99 (3H, s, Ac). 
13C NMR (500 MHz, CDCl3) ppm: 170.40, 170,37, 170.17, 170.09, 169.77, 169.74, 
169.08 (COCH3); 101.09 (Gal-1); 100.80 (Glc-1); 76.27, 72.70, 71.65, 71.00, 70.70, 
69.11, 67.34, 66.60, 61.97, 60.81; 21.07, 20.90, 20.82, 20.76, 20.65, 20.53 (COCH3). 
HRMS (ESI +) m/z: 779.1367 [M+Na]+; expected 779.1368 (C29H41BrO18Na). 
 
Synthesis of 1-(3-azidopropoxy) 2,2',3,3',4',6,6'-hepta-O-acetyl--lactoside 
Compound 1 (1.0 g, 1.32 mmol) was added to a suspension of NaN3 (0.429 g, 6.60 
mmol) in dry DMF (15 mL) at 80 °C for 16 h with stirring. The reaction mixture was 
concentrated in vacuuo, and the residue was diluted with CHCl3 (50 mL). The organic 
layer was washed with H2O and brine, dried over MgSO4, filtered, and concentrated 
in vacuuo to give a compound 2 (0.75 g, 75 %) as a colourless syrup. 
1H NMR (500 MHz, CDCl3) ppm: 5.37 (1H, d, J = 3.05 Hz, Gal-4); 5.22 (1H, t, J = 
9.31 Hz, Glc-3); 5.11 (1H, dd, J = 10.38, 8.09 Hz, Gal-2); 4.96 (1H, dd, J = 10.38 3.36 
Hz, Gal-3); 4.93 (1H, dd, J = 9.46, 8.09 Hz, Glc-2); 4.54 (1H, d, J = 1.68, Glc-1); 4.51 
(1H, d, J = 2.29, Glc-6); 4.50 (1H, d, J = 2.59, Gal-1); 4.18-4.08 (3H, m, Glc-6, Gal-
6, Gal-6); 3.95-3.91 (1H, m, CH); 3.89 (1H, t, J = 6.87 Gal-5); 3.82 (1H, t, J = 9.61 
Glc-4); 3.65-3.33 (5H, m, Glc-5, -CH2-); 2.18 (3H, s, Ac); 2.15 (3H, s, Ac); 2.09 (3H, 
s, Ac); 2.07 (3H, s, Ac); 1.99 (3H, s, Ac). 
13C NMR (500 MHz, CDCl3) ppm: 170.40, 170.37, 170,16, 170.09, 169.77, 169.66, 
173 
 
169.09 (COCH3); 101.10 (Gal-1); 100.59 (Glc-1); 76.25, 72.76, 72.68, 71.65, 70.99, 
70.70, 69.11, 66.60, 61.93, 60.80; 47.95(CH2CH2N3); 20.87, 20.82, 20.72, 20.65, 
20.53 (COCH3). 
HRMS (ESI +) m/z: 742.2283 [M+Na]+; expected 742.2277 (C29H41N3O18Na). 
 
Synthesis of 1-(3-azidopropoxy) -lactoside 
Compound 2 (700 mg, 0.97 mmol) was deacetylated with large excess of NaOMe in 
MeOH (30 % soln, 20 mL) in THF/MeOH (3:1, 80 mL) for overnight with stirring 
(not exceeding 10 °C). The reaction mixture was neutralized by acidic amberlite ion 
exchange resin. The residue was filtered and condensed in vacuuo to give a compound 
3 (240 mg, 34 %) as a colourless solid. 
1H NMR (500 MHz, CD3OD) ppm: 4.37 (1H, d, J = 7.63 Hz, Gal-1); 4.30 (1H, d, J = 
7.93 Hz, Glc-1); 4.00 (1H, m, CH); 3.90 (1H, dd, J = 12.36, 2.14 Hz, Glc-6); 3.83 (1H, 
dd, J = 10.53, 4.12 Hz, Glc-6); 3.80 (1H, d, J = 3.97, Gal-4); 3.73-3.64 (4H, m, Gal-6, 
Gal-6, -CH2-); 3.61-3.41 (9H, m, Gal-5, Gal-3, Gal-2, Glc-4, Glc-3, Gal-2, Glc-5, -
CH2-); 3.26 (1H, t, J = 8.39, Glc-2). 
13C NMR (500 MHz, CD3OD) ppm: 103.69 (Gal-1); 102.91 (Glc-1); 79.18, 75.69, 
75.05, 75.01, 73.43, 73.33, 71.16, 68.90, 66.23, 61.08, 60.49; 48.10 (CH2N3). 
HRMS (ESI +) m/z: 448.1541 [M+Na]+; expected 448.1538 (C15H27N3O11Na). 
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Synthesis of 1-(3-aminopropoxy) -lactoside 
To a mixture of compound 3 (200 mg, 0.47 mmol) in DMF (10 mL), PPh3 (246.55 mg, 
0.940 mmol) was added at 0 °C. The mixture was stirred at rt for 2 h. H2O (1.0 mL) 
was added and the reaction mixture was stirred at rt for 22 h until showing white 
precipitation (Ph3PO). The reaction mixture filtered and concentrated in vacuuo to 
give final product. 
1H NMR (500 MHz, D2O) ppm: 4.40 (1H, d, J = 8.09 Hz, Gal-1); 4.34 (1H, d, J = 7.78 
Hz, Glc-1); 3.99-3.95 (1H, m, -CH2-); 3.84 (1H, d, J = 3.20 Hz, Gal-6); 3.78 (1H, m, 
Gal-4); 3.80 (1H, d, J = 3.97, Gal-4); 3.76-3.61 (6H, m, Gal-6, Gal-5, Glc-6, Glc-6, 
Glc-4, -CH2-); 3.59-3.43 (6H, m, Gal-3, Glc-4, Glc-3, Glc-5, Glc-2, Gal-2); 3.07 (2H, 
t, J = 6.87, -CH2-). 
13C NMR (500 MHz, D2O) ppm: 102.91 (Gal-1); 102.03 (Glc-1); 78.38, 75.35, 74.77, 
74.34, 72.80, 72.10, 70.99, 69.64, 68.50, 67.90, 61.00, 60.46; 36.87 (CH2CH2NH2). 
HRMS (ESI +) m/z: 400.1815 [M+H]+; expected 400.1813 (C15H30NO11). 
 
End group modification of PFP-polyhydroxyethylacrylamide using 
galactosamine/lactosamine 
In a typical reacation, PFP-pHEA (50 mg, 0.024 mmol), galactosamine (25.2 mg, 
0.117 mmol) were dissolved in 5 mL DMF with 0.05 M triethylamine (TEA). The 
reaction was stirred at 50 °C for 16 hrs. The polymer was precipitated into diethyl 
ether from methanol three times and dried under vacuum. IR indicated loss of C=O 
stretch corresponding to the PFP ester. 
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General procedure for the synthesis of polymer-coated gold nanoparticles 
Approximately 1 mg of the pNIPAM or desired thiol-terminated GalNac-pHEA / Lac-
pHEA was added to a microcentrifuge tube, and dissolved in 100 L of high-purity 
water. For the thiol-terminated pNIPAM, ethanolamine (50 mol equiv of pNIPAM) 
was also added. 900 L of the citrated-stabilized gold nanoparticle solution was added 
to this tube (60 nm: 0.288 mmol L-1, 0.057 mg mL-1 total gold concentration), which 
was then agitated 30 mins in the absence of light. To remove excess polymer, the 
particles were centrifuged and following careful decantation of the supernatant, the 
particles were then re-dispersed in 1 mL of high-quality water and the centrifugation-
resuspension process repeated for a total of 3 cycles. After the final cycle the particles 
were dispersed in 1 mL of high-quality water for future use. Assuming complete 
incorporation of the citrate coated gold particles into the final polymer coated particles 
the total concentration of gold in the final solution was 0.259 mmol L-1, 0.051 mg  
mL-1. 
 
Gold nanoparticle functionalisation using a mixture of pNIPAM and Lac-pHEA 
(1 : 9 molar ratio) 
100 L of total polymer solution with different molar ratio between thiol-terminated 
DP50 pNIPAM (0.25 mg, 0.048 mol, 10 L) and Lac-pHEA (0.90 mg, 0.43 mol, 
90 L) was added to 900 L of 60 nm gold nanoparticles. Left for 30 minutes at room 
temperature and centrifuged to remove any attached polymer and resuspended in water. 
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Calcium and lectin induced aggregation studies by absorbance 
A stock solution of the Ca2+ or SBA was made up (0.1 mg mL-1 for SBA) in 10 mM 
HEPES buffer with 0.15 M NaCl, 0.1 mM CaCl2 and 0.01 mM MnCl2. 25 L serial 
Ca2+ (0.1 to 100 mM) or SBA (0 to 10 g mL-1) dilution was made up in the same 
buffer in a 96-well micro-titre plate. 25 L of the multi-polymer functionalised gold 
nanoparticle (0.051 mg mL-1 in water) were added to each well. Initial and after 30 
minutes, both absorbance spectrum were recorded from 450 nm – 700 nm with 10 nm 
intervals at 20 °C and 40 °C, respectively. 
 
Carbohydrate-carbohydrate interaction surface binding assays 
Greiner high binding 96-well plates (half volume) were incubated for 17 h with 
solutions of GM-3 (180 L of 0.1 mg mL-1 in PBS) per well. After incubation, 
unbound GM-3 was removed by washing vigorously with Milli-Q water, after which 
the plates were dried and stored at 4 °C. 50 L of gold nanoparticle solution (0.255 
mg mL-1 in water) and 5 L of Ca2+ solution (5 M in HEPES) were then added to 96-
well plates functionalised with GM-3 and incubated at room temperature and 40 °C 
for 1 h, respectively. After removing the unbound gold nanoparticles by extensively 
washing with Milli-Q water, the absorbance in each well was measured between 450 
and 700 nm in 1 nm steps. Finally, each well was prepared for SEM analysis. 
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Chapter 5 
5. Conclusions 
A great deal of interest in the integration of gold nanoparticles with responsive 
materials (polymer) is emerging for biological and biomedical applications. Due to the 
versatility of these nanostructures in biosensing and biorecognition among other areas, 
they are continuously being elucidated for a deep understanding of their functions, 
stimuli responsivity and the precise mechanism of their association generating signal 
outputs by environmental alteration or in the presence of specific target materials. 
In this work, firstly, we have demonstrated that temperature-responsive behaviour of 
poly(N-isopropylacrylamide) (pNIPAM) and pNIPAM functionalised gold 
nanoparticles for both fundamental studies on their aggregation behavior but also 
demonstrated a new platform for dynamic display of glycans, similar to ‘logic gates’ 
and the dynamic expression of glycans on cell surfaces. Smart polymer pNIPAM with 
a thiol-functional terminal group was synthesized via RAFT polymerization grafting 
onto the surface of pre-formed gold nanoparticles, exploiting the affinity and ease of 
thiol-gold self-assembly. Versatile ‘modular’ approaches to accessing many different 
thermo-responsive nanomaterials was introduced in Chapter 2.  
4 different mixing strategies were employed to fine-tune the transitions temperatures 
via co-operative assembly, rather than through tedious co-polymerizaton; i) different 
polymers on the same sized particles, ii) mixture of polymers on same sized particles, 
iii) same polymer on different sized particles and iv) different polymers on different 
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sized particles. In each case, the blending strategy enable the exact transition 
temperature to be tuned by simply mixing. Using TEM it shown that different sized 
nanoparticles preferentially interacted with each other, rather than themselves. This 
strategy may have applications in fine-tuning thermal responses for diagnostic or 
delivery applications and to improve out basic understanding of responsive 
nanostructures. 
Secondly, we have developed a temperature-switchable colourimetric sensing system 
to dissect protein-carbohydrate interactions. Two different functional polymers were 
co-grafted on the surface of gold nanoparticles. The multifunctionality of particles is 
based on the molecular recognition of galactose modified poly(hydroxyethyl 
acrylamide) (pHEA) and the thermo-sensitivity based on the coil-to-globule phase 
transition of pNIPAM.  
pNIPAM chains act as a reversible blocking agent, longer stretched linear pNIPAM 
chain shields lectin accessing to shorter Gal-pHEA chain below the LCST of the 
pNIPAM due to steric hindrance. Conversely, the galactosyl residues of pHEA is 
exposed by shrunken globular pNIPAM structure upon heating above LCST, this 
triggers crosslinking of particles exhibiting dramatic visible red-to-blue colour change 
of solution as a result of lectin-carbohydrate interactions. Quantitative detection of 
lectins associated with relative changes in particle aggregation can be simply 
monitored by a shift in the surface plasmon resonance peak (SPR) using UV-Vis 
spectroscopy. To get the optimum performance of particles as a biosensor, we 
optimised crucial parameters; i) size of core gold nanoparticles, ii) chain length of 
pNIPAM as a blocking agent and iii) molar ratio between Gal-pHEA and pNIPAM.  
9 : 1 molar ratio of Gal-pHEA and pNIPAM grafted 60nm sized gold nanoparticles 
have shown excellent dose dependent detection of target lectin with high sensitivity 
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(8.5 nM for SBA) and selectivity.  
Thirdly, we have successfully demonstrated that previous strategy with larger glycans 
(disaccharides) can be used to probe technically challenging low affinity 
carbohydrate-carbohydrate interactions. Whilst the literature on protein-carbohydrate 
interactions is vast, carbohydrate-carbohydrate interactions are often ignored. The 
surface of 60 nm gold nanoparticles was decorated with both shorter non-responsive 
disaccharides lactose modified pHEA and longer responsive pNIPAM which can 
undergo thermally-triggered coil to globule conformation transformation. 
Multivalent glyco-nanostructures where the expression of lactose at the particle 
surface can be triggered by an external temperature rise above the LCST of pNIPAM, 
and a gold nanoparticle core provides intrinsic colourimetric signal outputs by divalent 
calcium ion mediated lactose-lactose binding events, as confirmed by measuring the 
surface plasmon resonance (SPR) band using UV-Vis spectroscopy. TEM analysis 
was also conducted to support direct evidence of particle aggregation in the presence 
of calcium ion. Furthermore, these particles were subsequently employed to measure 
the interactions between the cancer-associated glycosphingolipds GM-3 and lactose, 
using a complimentary surface-binding assay to mimic a cell-surface interaction. The 
morphology of particle adsorption on glycolipids surface through Lactose-GM-3 
interactions were directly observed by SEM analysis. This method enables governing 
the expression of glycans which can control carbohydrate-carbohydrate interactions at 
desired condition compared to enzymatic control in Nature. 
In conclusion, these findings provide unique optical properties and thermo-responsive 
behaviour of polymer/gold hybrid nanoparticles in depth. Hopefully, these studies 
including switchable controlled specific targeting function of polymer tethered gold 
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nanoparticles in response to external temperature changing (by simply changing the 
temperature of media) will open up new horizons to the developments of precision 
multi-functional nanoparticles for in vitro and in vivo bio applications in the future.  
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Appendix 1 
Supplementary Information: Chapter 3 
Additional Characterisation 
 
Figure S1.1 X-ray photoelectron spectroscopy analysis of pHEA15-Gal(9) / 
pNIPAM50(1) functionalised 60 nm gold nanoparticles. A) Full survey scans B) 
Carbon (C1s) peak, C) Nitrogen (N1s) peak and D) Oxygen (O1s) peak. 
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Figure S1.2 X-ray photoelectron spectroscopy analysis of pHEA15-Gal(9) 
functionalised 60 nm gold nanoparticles. A) Full survey scans B) Carbon (C1s) peak, 
C) Nitrogen (N1s) peak and D) Oxygen (O1s) peak. 
 
 
Figure S1.3 X-ray photoelectron spectroscopy analysis of pNIPAM50(1) 
functionalised 60 nm gold nanoparticles. A) Full survey scans B) Carbon (C1s) peak, 
C) Nitrogen (N1s) peak and D) Oxygen (O1s) peak. 
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Supplementary Information: Chapter 4 
Additional Characterisation 
 
Figure S1.2 Non-coloured SEM image of A) Lac-pHEA15@Au60 at 20 ºC; B) 
GalNAc-pHEA15@Au60 20 ºC; C) Lac-pHEA15(9)/pNIPAM50(1)@Au60 at 20 ºC; D) 
Lac-pHEA15(9)/pNIPAM50(1)@Au60 at 40 ºC. 
  
A B
C D
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Appendix 2 
‘Unsuccessful’ experiments 
The increase in drug-resistant bacteria is one of the biggest threats to global health, 
food security, and development today due to human and animal infections caused by 
drug-resistant bacteria are harder to treat than those caused by non-resistant bacteria. 
The concept of this experiment is a development of nanoparticles responsive to drug-
resistant bacteria enzymes. The target enzyme is beta-lactamases (-lactamases), also 
known as penicillinase, which are produced by bacteria providing multi-resistance to 
antibiotics such as penicillins, cephalosporins, and carbapenems. -lactamase exhibits 
antibiotic resistance by breaking the -lactam ring (a four-atom ring) in the molecular 
structure of antibiotics through hydrolysis, which ultimately deactivates the 
molecule’s antibacterial properties, as shown in Figure S2.1. 
 
Figure S2.1 The action of -lactamase and decarboxylation of the intermediate. 
-Lactamase
- CO2
Hydrolysed intermediate
Decarboxylated product
Amoxicillin
190 
 
In this study, amoxicillin and penicillinase were used as a model antibiotics and 
enzyme. The enzyme action of -lactamase involving hydrolysis and decarboxylation 
of the intermediate are successfully confirmed by mass spectroscopy analysis. 
 
Figure S2.2 Mass spectrum (negative mode) of amoxicillin (1 mg mL-1) upon addition 
of -lactamase (15-30 units) for 30 mins incubation at room temperature.  
 
Next, antibiotics conjugated thermo-responsive polymers were synthesized to 
investigate the phase transition properties in the presence of enzyme. Two different 
molecular weight of pentafluorophenyl (PFP) ester modified poly(-isopropyacryl 
amide) (PFP-pNIPAM) were synthesized via RAFT polymerization. Polymers have 
Amoxicillin
[M-H]-: 364.0967
Hydrolysed intermediate
[M+H2O-H]-: 382.1073
Decarboxylated product
[M-CO+2H-H]-: 338.1175
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narrow molecular weight distributions as confirmed by SEC analysis (Figure S2.3B 
and Table S2.1), and then fluorophenyl esters end group was subsequently reacted with 
primary amines (-NH2) in the amoxicillin to form a stable amoxicillin conjugated 
pNIPAM through amide bond.  
 
Figure S2.3 A) Synthetic route to amoxicillin conjugated pNIPAMs; B) SEC analysis 
of polymers. 
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Table S2.1 Polymer synthesis and characterisation. 
Polymer [M]:[CTA]:[I] 
(-) 
Conversion(a) 
(%) 
Mn(Theo)(b) 
(g mol-1) 
Mn(SEC)(c) 
(g mol-1) 
Mw/Mn 
(-) 
PFP-pNIPAM20 20:1:0.2 89 % 2000 3200 1.10 
PFP-pNIPAM50 50:1:0.2 90 % 5100 7000 1.12 
PFP-pNIPAMxxx = pentafluorophenyl poly(N-isopropylacrylamide) where average 
degree of polymerization indicated by xxx; (a) determined by 1H NMR; (b) From 
[M]:[CTA] and 1H NMR; (c) Compared to PS standards. 
 
Infrared analysis of pNIPAM was conducted before and after reaction of PFP end-
group with amoxicillin. Disappearance of C=O at around 1777 cm-1 attributable to the 
carbonyl associated with the PFP end-group being removed as shown in Figure S2.4. 
 
Figure S2.4 Infrared spectra of PFP-pNIPAM (red) and Amoxicillin-pNIPAM (blue). 
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In order to characterise the temperature response of synthetic polymers, the cloud point 
(CP) of each polymer was determined by UV-vis spectrometer. Independent transition 
curves of turbidimetry scans Figure S2.5 and Table S2.2 showed both amoxicillin 
modified pNIPAM with DP50 and pNIPAM with DP20 have higher CPs than CPs of 
PFP-pNIPAMs. Moreover, short amoxicillin conjugated pNIPAM with DP20 has no 
transition temperature upon heating up to 75 oC, the polymer chain may have increased 
solubility and hydrophilicity associated with end group modification. Therefore, 
amoxicillin conjugated pNIPAM with DP50 was used for further study to probe the 
enzyme effects on the transition temperature of antibiotic modified temperature 
responsive polymer. 
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Figure S2.5 Turbidimetry scans (absorbance at 700 nm) of two different molecular 
weight of PFP-pNIPAMs and Amoxicillin-pNIPAMs (total concentration of polymer 
solution 1.0 mg mL-1). 
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Table S2.2 Cloud points of polymers. 
Polymer Cloud point [°C]a) 
PFP-pNIPAM20 39 
Amoxicillin-pNIPAM20 - 
PFP-pNIPAM50 42 
Amoxicillin-pNIPAM50 52 
a)Cloud points were measured in water upon heating from 25 °C to 75 °C, 1.0 mg mL-
1 total polymer concentration. 
 
Finally, enzyme induction study was conducted using both PFP-pNIPAM50 (as a 
control experiment) and amoxicillin conjugated pNIPAM50. The cloud point of 
polymer solution is measured in the absence of the -lactamase and in the presence of 
15-30 units of -lactamase for 30 minutes incubation at room temperature without any 
further purification. From turbidimetry scans Figure S2.6 and Table S2.3, there were 
no changes of transition temperature of PFP-pNIPAM with or without enzyme. -
lactamase had no affects at all to PFP-pNIPAM polymer which doesn’t contain the -
lactam ring, as expected. The cloud point of Amox-pNIPAM50 has an increased 
transition temperature of 55 oC in the presence of enzyme, this value was 5 degree 
higher than transition temperature without enzyme. The shift of cloud point may result 
from the alteration of hydrophilicity of polymer chain due to the enzyme lysed 
amoxicillin. 
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Figure S2.6 Turbidimetry scans (absorbance at 700 nm) of PFP-pNIPAM50 and 
Amoxicillin-pNIPAM50 with or without -lactamase (total concentration of polymer 
solution 1.0 mg mL-1). 
 
 
Table S2.3 Cloud points of polymers. 
Polymer Cloud point [°C]a) 
PFP-pNIPAM50 42 
PFP-pNIPAM50 + -lactamase 42 
Amoxicillin-pNIPAM50 52 
Amoxicillin-pNIPAM50 + -lactamase 57 
a)Cloud points were measured in water upon heating from 25 °C to 75 °C, 1.0 mg mL-
1 total polymer concentration with or without -lactamase. 
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We observed the transition temperature of antibiotic modified pNIPAM is increase by 
enzyme reaction associated with hydrophilicity/hydrophobicity of polymer chain. 
However, from previous work in the chapter 2, the similar molecular weight of 
pNIPAM coated gold nanoparticle has higher transition temperature (e.g. CP of 
pNIPAM50 coated 40 nm sized gold nanoparticle is 80
oC) than pure polymer its own. 
Consequently, polymer functionalised particles has extremely higher or even no 
transition temperature which unable particles to generate aggregation mediated 
colourimetric visible signal outputs. These problems are current challenges facing the 
use of antibiotics functionalised gold nanoparticles as an enzymatic biosensor. It is 
noteworthy that several crucial factors (conditions) have to be considered and 
optimised such as polymer chain length, core particle size, enzyme concentration, 
incubation time, hydrophilicity/hydrophobicity of antibiotics, enzyme toxicity of gold 
nanoparticles for the future ‘success’ of the enzymatic biosensor. 
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